|
Amylin
leads drug stocks lower
Marketwatch
8/19/08
Byetta
woes threaten wider diabetes drug class
Guardian,
UK 8/19/08
Merck
Vioxx study was for marketing: researchers
Reuters
8/19/08
Novo
Nordisk Expects Stronger Warning Requirements From FDA
Bloomberg
8/19/08
Replenishing
The Pipeline: And The Winner Is…
Pharmalot
8/19/08
King
Pharma says Remoxy pain drug Phase III successful
Marketwatch
8/19/08
Anatomy
of The Amylin Drug Warning
CNBC
8/19/08
Johnson
& Johnson: The Type of Growth Stock I Favor
Seeking
Alpha 8/19/08
[video]Street
Insider: Pharma
CNBC
8/19/08
Some
Biotechs Get a Bounce
Barrons
8/19/08
Would
Genentech Be Better Off Left Alone by Roche?
Seeking
Alpha 8/19/08
Johnson
& Johnson's New High
Seeking
Alpha 8/19/08
Biotech
ETFs: Can You Handle 209% Volatility?
Seeking
Alpha 8/19/08
Genentech
and Roche, Act Two
In
the Pipeline 8/19/08
AstraZeneca
Gives FluMist Spray a Shot in the Arm
Seeking
Alpha 8/19/08
Biotech:
When Breaking Up Isn't Hard to Do
Motley
Fool 8/19/08
Vertex,
J&J to Begin New Telaprevir Study
TheStreet.com
8/19/08
Vertex
to begin expanded trial for hepatitis drug
Bizjournals.com
8/19/08
Dyax
Gains With Test Results
Forbes
8/19/08
Cell
Therapeutics Q2 loss: $59M
Bizjournals.com
8/19/08
Medtronic
expected to show lower operating costs, higher sales of stents
in first quarter
Yahoo/AP
8/19/08
|
|
Allergan:
When Deals Get Ugly
SeekingAlpha
8/18/08
Drug
stocks edge higher, while Dyax rockets
Marketwatch
8/18/08
Time
to Invest in Pharmaceuticals?
SeekingAlpha
8/18/08
Browsing
in the Biotech Aisle
Barron's
8/18/08
Sales
Reps, Doctors & ‘Emotional Connections’
Pharmalot
8/18/08
New
England Journal Editors File Brief Against Wyeth
Bloomberg
8/18/08
For
Bristol, steady course may be best navigation
Guardian/Reuters
8/18/08
Roche
Sues Drugmakers to Block Generic Boniva Osteoporosis Drug
Bloomberg
8/18/08
Roche
sells four products to Meda
Hays
Pharma 8/18/08
Schering-Plough
Expands Its Presence In China, Enters Next Stage Of Development
Pharmaceutical
Online 8/18/08
Enzon
Pharma Risks Balanced
Yahoo/Zacks.com
8/18/08
For
Cubist, a tough sell
Boston
Globe, MA 8/18/08
Texas
Suspends Psych Drug Program For Kids
Pharmalot
8/18/08
J&J
Wins Favored Status
By Curing Statue Fungus Woes
WSJ
Online 8/18/08
Ardea
Biosciences Still Developing
Yahoo/Zacks.com
8/18/08
|
|
5
Potential Buyout Targets in Biotech - Barron's
Seeking
Alpha 8/17/08
Four
Drug Companies Vying for Diabetes Patients
Seeking
Alpha 8/17/08
Teva's
accounting exercise
Globes,
Isreal 8/17/08
Drug
chief hits back at pharmaceutical firms (in the UK)
inthenews.co.uk,
United Kingdom 8/17/08
Recruiters
eye Genentech employees
San Francisco Chronicle, CA 8/17/08
Genentech
Pipeline: Too Good To Settle for Less?
Seeking
Alpha 8/16/08
Report:
Analysts peg Genentech price at $107.50 a share
Bizjournals 8/16/08
Biotech-Stock
Mailbag: Genentech
The
Street 8/16/08
Drug
stocks mixed; Elan continues rebound
MarketWatch
8/16/08
Tongjitang
Chinese Medicine: Earnings Up, But Counterfeits Hurt Sales
Seking
Alpha 8/16/08
WuXi:
Solid Earnings, Solid Outlook
Seking
Alpha 8/16/08
Significant
Reduction In Rate Of Lung Function Decline Achieved In COPD Patients
Receiving Seretide®/Advair®
Medical
News Today 8/16/08
Dendreon
Risk: Delays with Provenge
Yahoo/Zacks
8/16/08
Sun Pharma announces US FTC clearance for Taro tender offer
Trading
Markets 8/16/08
Drug
Company Comes In A Day Late, But Not A Dollar Short
Yahoo/Investor's
Business Daily 8/16/08
Catalyst
Pharmaceutical Q2 losses nearly double
Triangle
Business Journal, NC 8/16/08
Accentia
Biopharmaceuticals sees Q3 loss narrow, receives Nasdaq notice
Bizjournals
8/16/08
NUCRYST
Receives Deficiency Notice from NASDAQ
CNW
Telbec, Canada 8/16/08
AMDL
Q2 Net Loss Narrows On 140% Revenue Growth
RTT
News 8/16/08
FDA
approves 1st drug for Huntington's disease
Newsday
8/16/08
Personalized
Immunotherapy To Fight HIV/AIDS
Science
Daily 8/16/08
MethylGene
Provides Update on Suspension of New Enrollment in MGCD0103 Clinical
Trials
Genetic
Engineering News 8/16/08
Spectrum
Pharmaceuticals Launches FUSILEV(TM)
Yahoo
8/16/08
Drug
Ads Losing Recall Effectiveness Among Consumers
BrandWeek
8/16/08
Pharma
donors favor Obama
Medical Marketing and Media 8/16/08
Gen-Probe
blood assay gets FDA approval for hepatitis B
SmartBrief
8/16/08
|
|
Abbott
and AstraZeneca to co-market Crestor
Yahoo/AP
8/14/08
Schering
Drug Derailed by Power of One
TheStreet.com
8/14/08
Genentech
says 'no' to Roche
Trading
Markets 8/14/08
Schering
Regroups After FDA Rejection
TheStreet.com
8/14/08
Updates
on the Healthcare/Biotech Mergers
Seeking
Alpha 8/14/08
Elan
to Reward Investors Braving MS Drug's Brain Risk
Bloomberg
8/14/08
Novartis
MS drug may work against viral infection: study
Reuters
8/14/08
Schering-Plough
Takes Sole Possession of Its China JV
SeekingAlpha
8/14/08
Wyeth
extends atherosclerosis partnership
Yahoo/AP
8/14/08
Physicians
Expect to Shift More Time to Online Professional Resources in
the Coming Years
Trading
Markets 8/14/08
SGX
- Lilly Merger Offer Receives Positive Opinions From Proxy Advisory
Firms
PR
Newswire 8/14/08
Indevus
Pharmaceuticals says overactive bladder treatment gets patent
protection through 2025
Yahoo/AP
8/14/08
Stents,
Drugs or Both: Debate May Get New Life
CNBC
8/14/08
FDA
approves Gilead's Viread for chronic hepatitis B treatment in
adults
Pharmaceutical
Business Review 8/14/08
Lilly
helps fund MS drug trial
Chronicle-Herald,
Canada 8/14/08
WuXi
PharmaTech Earnings Seem Stellar
SeekingAlpha
8/14/08
FTC
Challenges Sun Pharmaceuticals' Purchase of Taro Pharmaceutical
Industries
Trading
Markets 8/14/08
Cardiome
and Astellas receive FDA approvable letter for Kynapid injection
Pharmaceutical
Business Review 8/14/08
Dendreon
Initiates Second of Two New Phase 2 Trials of PROVENGE for Prostate
Cancer
Yahoo
8/14/08
|
|
Strict
Law to Curb Physician Gifts
PharmExec
8/13/08
CSL
to Buy Talecris for $3.1 Billion in Record Buyout
Bloomberg
8/13/08
Is
Big Pharma Finally Back?
CNBC
8/13/08
Pharma
sales to physicians: emotions beat evidence
Fierce
Pharma 8/13/08
Bids
for embattled Elan arm pitch value of unit at $1.4bn
Irish
Independent 8/13/08
Are
Big Pharma's Dollar Days Nearly Over?
Seeking
Alpha 8/13/08
Lilly
would bolster pipeline
Indianapolis
Star, IN 8/13/08
Pharmaceutical
giants tracking Mylan's prosperity
Pittsburgh
Tribune Review, PA 8/13/08
My
Model Biotech Picks: What's Hot and What's Not
Seeking
Alpha 8/13/08
Dendreon
Earnings Stay Put
Forbes
8/13/08
Dendreon
Banks On October
Forbes
8/13/08
FDA
warns of skin reactions seen with injectable alcoholism treatment
from Cephalon, Alkermes
Yahoo/AP
8/13/08
Ranbaxy
Drugs Win Approval Amid Probe Whether Data Were False
Bloomberg
8/13/08
ANALYSIS-New
US drug rulings may confuse investors
Forbes
8/13/08
Cramer's
Latest Biotech Buy
CNBC
8/13/08
Don't
Discard Omrix
Motley
Fool 8/13/08
The
FDA Stands Up Cardiome
Motley
Fool 8/13/08
Biovail
Has Loss in Second Quarter; Revenue Declines
Bloomberg
8/13/08
Altus
Shares Plummet on Drug Trial
TheStreet.com
8/13/08
Lundbeck
Profit Drops After Alzheimer Drug Failure
Bloomberg
8/13/08
Anesiva:
Painless Going Forward?
Yahoo/Zacks.com
8/13/08
|
|
[video]Cramer:
Bristol's Bid to Beat Cancer
CNBC
8/12/08
Pfizer
Breaks A Barrier
CNBC
8/12/08
Pfizer
to lose top spot by 2014
InPharmaTechnologist
8/12/08
Big
Pharma’s Healthy Appetite for Acquisitions
Seeking
Alpha 8/12/08
By
How Much Will Roche Increase Its Valuation for Genentech?
Seeking
Alpha 8/12/08
Drugmakers:
We Couldn’t Guess How Much Those Lawsuits Might Cost
WSJ
Online 8/12/08
Icahn
Increases Biogen Idec Stake to 6.03 Percent
Bloomberg
8/12/08
Elan
seeks fast sale of drug delivery unit-sources
Guardian,
UK 8/12/08
Enzon's
Split Ends
Forbes
8/12/08
Pain
Therapeutics, King drug gets priority review
Yahoo/AP
8/12/08
Sanofi-Aventis
Sues Apotex Over Taxotere US Patents
Easy
Bourse, France 8/12/08
Schering-Plough
Expands Its Presence in China, Enters Next Stage of Development
PharmaLive
8/12/08
Drugmakers
protest plan on legal costs: report
Boston
Globe, MA 8/12/08
J&J
unit Ethicon Endo-Surgery to buy SurgRx
Yahoo/AP
8/12/08
Enzon
co-founder returns with new biotech
Star
Ledger, NJ 8/12/08
FDA
approves Gilead's Viread for hepatitis treatment
bizjournals.com
8/12/08
Dynavax
and Merck Announce Phase 3 Trial with Investigational Hepatitis
B Vaccine Met its Primary Endpoint
Admet
8/12/08
PDL
BioPharma Q2 profit jumps to $33.9M
bizjournals.com
8/12/08
|
|
Bristol-Myers
and ImClone Tussle Over Follow-Up to Erbitux
WSJ
Online 8/11/08
Will
Roche Go "Crazy" For Genentech?
CNBC
8/11/08
Biogen-Idec,
Elan: Panic Selling Creates Interesting Opportunity
Seeking
Alpha 8/11/08
Bayer’s
high hopes for new drug that prevents blood clots
The
Post, Ireland 8/11/08
Johnson
& Johnson Profit-Taking Likely, Offering Better Entry Point
Seeking
Alpha 8/11/08
Just
What the Doctor Ordered: Healthcare and Biotech ETF Review
Seeking
Alpha 8/11/08
China
Biotech Week in Review: Earnings and More
Seeking
Alpha 8/11/08
Daiichi
Sankyo to Begin Ranbaxy Tender on Aug. 16
Bloomberg
8/11/08
Valeant
posts 2nd-quarter loss on lower sales and higher taxes, but shares
hit year high
Yahoo/AP
8/11/08
Heath
Ledger's Legacy For Drug Marketers
Brandweek
8/11/08
Inspire
Pharmaceuticals tops Wall Street sales estimates
bizjournals.com
8/11/08
Clarient:
Clearly a Winner
Seeking
Alpha 8/11/08
Ready
for Dr. Reddy's Labs
Seeking
Alpha 8/11/08
Cardiome
And Astellas Announce Receipt Of FDA Approvable Letter For KYNAPID(TM)
Yahoo
8/11/08
Drug
companies kicking up prices on rarer treatments
InForum
8/11/08
Alnylam
Pharma Seeks Alliances
Yahoo/Zacks.com
8/11/08
Enzon
Explores Selling Off Single Drugs, or Division
Bloomberg
8/11/08
|
|
Determined
Elan stands by Tysabri drug despite market worries
Westmeath
Independant, Ireland 8/10/08
Phase
3 Trial With Investigational Hepatitis B Vaccine (HEPLISAV) Met
Primary Endpoint
Medical
News Today 8/10/08
Lilly
taps hedge fund
Indianapolis
Business Journal 8/9/08
Biotech
Stocks Regain Some Lost Ground
The
Street 8/9/08
Somaxon
Drug Awaits Approval
Trading
Markets 8/9/08
BRIDION(R) (sugammadex) Injection - First And Only Selective Relaxant
Binding Agent - Approved In European Union
Medical
News Today 8/9/08
GlaxoSmithKline
And Genmab Announce Positive Top-line Results In Ofatumumab Chronic
Lymphocytic Leukaemia Pivotal Study
Medical
News Today 8/9/08
Enrollment
in Phase IIb Clinical Trial for I-Vation(TM) TA (MK-0140) Suspended
Pending Review of Study Design By Merck & Co., Inc.
Red
Orbit 8/9/08
Bristol-Myers
Squibb Launches Secure The Future® Technical Assistance Program
To Optimize Community Services For Comprehensive HIV Management
Medical
News Today 8/9/08
Warner
Chilcott Q2 Profit Rises On Higher Sales, Lower Expenses, Backs
FY08 Outlook
RTT
News 8/9/08
Movers
roundup: Par Pharma, Alkermes
CNN
Money 8/9/08
Watson
Pharmaceuticals Announces Limited Recall of Fentanyl Transdermal
System (with correction)
Earth
Times 8/9/08
Lorus
Therapeutics Successfully Completes Rights Offering, Raising $3.71
Million
CNN
Money 8/9/08
Sound
Pharmaceuticals wins FDA approval for Phase II hearing loss study
Pharmaceutical
Business Review 8/9/08
Shareholder
Alert: The Rosen Law Firm Announces Investigation of Dilutive
Financing of Genta Incorporated
Yahoo
8/9/08
Novavax widens loss
Bizjournals
8/9/08
Aradigm's
Q2 loss grows
Triangle
Business Journal 8/9/08
IntelliPharmaCeutics
Provides Update on Activities
CNW
Telbec , Canada 8/9/08
Cytori
Therapeutics shares fall on wider 2Q loss
Yahoo/AP
8/9/08
Labopharm
reports results for second quarter fiscal 2008
CNW
Telbec , Canada 8/9/08
GenVec
reports $6.5 million loss
Bizjournals
8/9/08
Keryx
Biopharmaceuticals, Inc. Announces Second Quarter 2008 Financial
Results
MSN
Money 8/9/08
BioSante
Pharmaceuticals Reacquires Elestrin
Pharmpro
8/9/08
|
|
King
Pharma tumbles on weak sales
Marketwatch
8/7/08
The FDA's Black Box
Forbes
8/7/08
Be
Selective with Medical Device Companies
Seeking
Alpha 8/7/08
GlaxoSmithKline
pays $15 million to Tolerx
Bizjournals
8/7/08
GSK:
Pooled-Analysis of 54 Clinical Studies Shows No Increased Risk
of Heart Attack With Abacavir Therapy
Yahoo
8/7/08
Rituxan
may heal common kidney condition
Reuters
8/7/08
J&J
Submits NDA for Anti-Coagulant Xarelto
FDA
News 8/7/08
Novartis
says started Fluvirin shipment to U.S.
Forbes
8/7/08
Exelixis
Gets Ready to Partner Up
Motley
Fool 8/7/08
Genzyme
inks deal
Bizjournals.com
8/7/08
Isolagen
Smiles
Forbes
8/7/08
Pfizer,
Roche Cancer Drugs Rejected by U.K. Agency on Cost
Bloomberg
8/7/08
Amgen
Should Start Paying a Dividend
Seeking
Alpha 8/7/08
Novo
Nordisk H1 profit up, outlook hits shares
Reuters
8/7/08
Lilly's
$1.6 billion deal with Covance aimed at cutting R&D costs
PharmaTimes,
UK 8/7/08
FDA Calendar: Cardiome, Momenta, Discovery Labs, Introgen
Seeking
Alpha 8/7/08
Acambis
Revenue Doubles As Holders Mull Sanofi Offer
Easy
Bourse 8/7/08
Barr
Pharmaceuticals reports 2Q profit increase
Yahoo/AP
8/7/08
Isis
narrows second-quarter loss
Marketwatch
8/7/08
Onyx
in the Black -- for Now
Motley
Fool 8/7/08
Illumina
Grabs Some Cash
Motley
Fool 8/7/08
|
|
Novartis
Shares Fall the Most Since July on JPMorgan Downgrade
Bloomberg
8/6/08
Novartis
to sell generic Plavix for 25 pct less
Reuters
8/6/08
Merck
Asthma Drug Gets Wind Knocked Out Of It
Easy
Bourse 8/6/08
Bayer
takes Sandoz to court in bid to defend Yaz patents
PharmaTimes,
UK 8/6/08
J&J
pays up for Pfizer consumer unit error
Fierce
Pharma 8/6/08
Mylan
posts loss on acquisition items
Reuters
8/6/08
FDA
Approves 2008-2009 Flu Vaccines
Trading
Markets 8/6/08
Genentech’s
New ADC Platform Has Much Potential, but Is Yet to Be Tested on
Humans
Seeking
Alpha 8/6/08
Status
shift predicted for drug firms
Newark
Star Ledger, NJ 8/6/08
Zacks
Analyst Blog Highlights: Regeneron, Sanofi-Aventis S.A., AstraZeneca,
Ambac Financial and Citigroup
Trading
Markets 8/6/08
Eli
Lilly Charmed by China High Growth Potential
Trading
Markets 8/6/08
Analysts'
Upgrades, Downgrades: Elan
TheStreet.com
8/6/08
Ariad
Pharmaceuticals to receive $2.5 million from partner Merck for
cancer drug development
Yahoo/AP
8/6/08
Adolor
Turns to profit in Q2
RTT
News 8/6/08
BioMarin
Pharmaceuticals shares dive on Kuvan sales, Wall Street maintains
positive outlook
Yahoo/AP
8/6/08
Growing
Nexavar Sales Boost Onyx Q2
Bizjournals
8/6/08
Abbott's
Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated
Similar Clinical Results Across Race and Gender Lines
Yahoo
8/6/08
|
|
ImClone
- Bristol-Myers Merger: The Negotiations Begin
Seeking
Alpha 8/5/08
Icahn
Responds to BMS Offer for ImClone
Seeking
Alpha 8/5/08
Daiichi
Wins Approval to Buy Ranbaxy After Hurdles
Bloomberg
8/5/08
Health
Winners & Losers: Elan
TheStreet.com
8/5/08
Roche
tipped to be world's top drugmaker by 2014
Forbes/Reuters
8/5/08
Pfizer
Tries To Bully Law Firm Into Celebrex Deal
Pharmalot
8/5/08
Wyeth
gets subpoenas tied to Protonix
Yahoo/Reuters
8/5/08
Bayer
sues Novartis unit over generic contraceptive
Hemscott,
UK 8/5/08
Schering-Plough
drug results pressure Vertex stock
IT
BusinessNet 8/5/08
Increasing
M&A Activity in the Generics Industry: What happens next?
OBBeC
8/5/08
SuperGen swings to Q2 loss, tightens belt
Bizjournals.com
8/5/08
NitroMed
swings to profit
Bizjournals.com
8/5/08
Pharmacopeia
to lay off approximately 40% of workforce
Marketwatch
8/5/08
Medicines
Co. gets lift from drug approval
Star
Ledger, NJ 8/5/08
Gilead
anti-AIDS gel might help men too, study finds
Reuters
8/5/08
Valeant
to sell certain European business operations to Meda
Pharmaceutical
Business Review 8/5/08
Estrogen
May Ease Schizophrenia Symptoms in Women, Study Finds
Bloomberg
8/5/08
Astellas
introduces antifungal agent Mycamine in UK
Pharmaceutical
Business Review 8/5/08
Pharmasset
hepatitis C drug candidate meets safety goals in early-stage study
Yahoo/AP
8/5/08
|
|
ImClone
To Bristol: Gimme More
Forbes
8/4/08
Lilly
says $3-a-share bid for SGX is best and final offer
Marketwatch
8/4/08
What
Are Your Biogen Idec Options?
SeekingAlpha
8/4/08
Schering-Plough
stunned by FDA's rejection of Bridion
Pharma
Times, UK 8/4/08
Novartis
says FDA OKs Diovan HCT and Exforge Single-Pill Combinations as
first-line treatments for high BP
RTT
News 8/4/08
Verispan:
Merck Advances to No. 1 with Managed Care Executives
iStockAnalyst
8/4/08
Time
to Buy Elan?
Seeking
Alpha 8/4/08
GlaxoSmithKline
Trims Down Oncology Head Count
Seeking
Alpha 8/4/08
A
Second Chance to Buy Wyeth?
Barron's
8/4/08
Brain
Drain For Biogen, Elan
Forbes
8/4/08
Abbott
faces more litigation over AIDS drug
Yahoo/AP
8/4/08
China
Biotech in Review: Company Profiles and Drug Advancement
Seeking
Alpha 8/4/08
UCB's
first-half net income falls on weaker Zyrtec sales
Pharma
Times, UK 8/4/08
Astellas
Shares Rise to 2008 High on Profit Outlook
Bloomberg
8/4/08
KV
Pharmaceutical's Motion for Rule 11 Sanctions in Ritalin LA Case
Denied
Seeking
Alpha 8/4/08
Marcial:
Clinical Data Is a Biotech to Watch
Businessweek
8/4/08
Gilead
AIDS Drugs May Hold Key to Prevent Infections
Bloomberg
8/4/08
FDA
OKs Medicines Co.'s Cleviprex
TheStreet.com
8/4/08
The
Technician: Healthcare ETFs Stage Recovery
Seeking
Alpha 8/4/08
La
Jolla Pharma 2Q loss rises on research costs
Yahoo/AP
8/4/08
Karo
Bio Gains Most in 3 Years After Drug Study
Bloomberg
8/4/08
|
|
Elan
Becomes a Bad News Buy
The
Motley Fool 8/2/08
Bristol-Myers
sells ConvaTec wound-care unit
BusinessWeek
8/2/08
Holy
Moley, CV Therapeutics!
Motley
Fool 8/2/08
FDA
rejects Schering-Plough drug
Bizjournals
8/2/08
AstraZeneca
Battling Generics
Yahoo/Zacks
8/2/08
Daiichi
says terms of open offer for Ranbaxy may change
Economic
Times 8/2/08
Cell
Genesys Q2 loss widens on lower tax benefit
RTT 8/2/08
Oscient
Pharma Posts Wider Loss In Q2; Cuts FY08 Revenue Outlook
RTT
8/2/08
Drug
firms go slow on patent challenges
MSN
India 8/2/08
|
|
Bristol-Myers
offering $4.5 billion for ImClone
Yahoo/AP
7/31/08
FDA:
More Label Warnings for Anemia Drugs
TheStreet.com
7/31/08
Sanofi
Profit Falls as Top-Selling Drugs Miss Analyst Estimates
Bloomberg
7/31/08
Lilly
Trained Sales Force to Ignore Drug's Risks, Documents Say
Bloomberg
7/31/08
AstraZeneca
ups outlook after 14% profit rise
Marketwatch
7/31/08
J&J,
Bayer seek FDA approval for anticlotting drug
Yahoo/AP
7/31/08
Takeda
Raises Profit Forecast on Millennium Purchase
Bloomberg
7/31/08
Eisai
Profit Falls 14% on MGI Pharma Acquisition Cost
Bloomberg
7/31/08
Baxter
boosted by drug's head start: Alzheimer's candidate used for other
diseases
Trading
Markets 7/31/08
[video]Medivation
unveils positive test results for its Alzheimer's drug
CNBC
7/31/08
Phase
II Data on Lilly's Antibody Show It Affects Amyloid Beta, a Protein
Believed To Be Associated with Alzheimer's Disease
Yahoo
7/31/08
Teva
Has Revenue in All the Wrong Places
Motley
Fool 7/31/08
Glaxo
says therapeutic vaccines hold big promise
Reuters,
UK 7/31/08
Longer-Acting
Relenza Fights Flu as Well as Tamiflu
Bloomberg
7/31/08
Baxter
boosted by drug's head start: Alzheimer's candidate used for other
diseases
Trading
Markets 7/31/08
Endo
Pharma Q2 profit tops Street, backs '08 view
Reuters,
UK 7/31/08
Abbott
agrees to pay as much as $27.5M to settle AIDS patients' antitrust
lawsuit
Yahoo/AP
7/31/08
Elan,
Wyeth tumble on Alzheimer's study
Marketwatch
7/31/08
Roche
files MabThera for leukaemia treatment in EU
Reuters,
UK 7/31/08
Generic
drug backlog to spike: FDA official
Reuters
7/31/08
Hey,
Drug Researchers, Lotsa Luck!
WSJ
Online 7/31/08
Genta
Tempered by Trial Costs
Yahoo/Zacks.com
7/31/08
Quark,
Pfizer start Phase II dosing
MSN
Money 7/31/08
|
|
Drug
Marketing Poised For Historic Decline
Brandweek
7/30/08
Alzheimer's
Drug Showdown
Forbes
7/30/08
US
approves generics of Abbott seizure drug
Reuters,
UK 7/30/08
Eli
Lilly with Pipeline Issues
Yahoo/Zacks.com
7/30/08
Earnings
Preview: Allergan
SeekingAlpha
7/30/08
Avoid
Value Traps Like Merck and Pfizer
TheStreet.com
7/30/08
Novartis's
bone drug recommended for treatment of osteoporosis in men
Trading
Markets 7/30/08
Time
for Biotech? - Fast Money Recap
SeekingAlpha
7/30/08
Marcial:
Drugmaker Pfizer, a 'Fallen Angel?'
Businessweek
7/30/08
Boring
is good at Teva
Globes,
Israel 7/30/08
Bayer
2Q net profit slips 13 percent
IHT
7/30/08
Pozen:
Migraine pill's success hinges on FDA
Trading
Markets 7/30/08
Elan
Corp.: Bounce on Goldman Positivity?
SeekingAlpha
7/30/08
Cephalon
Beats Profit Targets
TheStreet.com
7/30/08
Biotech
Bucks the Market Trend
SeekingAlpha
7/30/08
Buzzkill
For Sepracor
Forbes
7/30/08
Health
Winners & Losers: Amgen
TheStreet.com
7/30/08
Amgen,
Alexion Pharmaceuticals Surge On Healthy Earnings, Positive Drug
Trial
Investor's
Business Daily 7/30/08
Vanda's
Schizophrenia Drug Goes Down for the Last Time
SeekingAlpha
7/30/08
GenVec
wins funding for foot-and-mouth vaccine program
Bizjournals.com
7/30/08
Mylan
buys out Watson’s interest in Somerset Pharmaceuticals
Bizjournals.com
7/30/08
Alexion
Pharmaceuticals shares hit new high on swing to 2Q profit, outlook
for key drug sales
Yahoo/AP
7/30/08
Novo
Nordisk employee charged with insider trading
Yahoo/AP
7/30/08
Cohen's
SAC Boosts Stake in Invitrogen to 6.9%
SeekingAlpha
7/30/08
|
|
Amgen
Posts Profit Beat
TheStreet.com
7/29/08
Study:
Novartis' blood pressure drug Exforge outperforms Norvasc
StarLedger,
NJ 7/29/08
Pfizer
Wins Dismissal of Price-Fixing Lawsuit by Drugstores
Bloomberg
7/29/08
Sepracor
2nd-qtr profit jumps on tax benefit, falls short of Street view;
revenue outlook cut
Yahoo/AP
7/29/08
Abbott
Laboratories: The Choice Within Big Pharma
SeekingAlpha
7/29/08
I
Still Like Amgen - Despite the Recent Run-up
SeekingAlpha
7/29/08
Biotech:
New Hottie of the Market
iStockAnalyst
7/29/08
GlaxoSmithKline
payment boosts Pozen earnings
Bizjournals.com
7/29/08
Amgen's
D-mab Delights Investors
Seeking
Alpha 7/29/08
Teva
Getting Even More Generic, Coach Plans to Be Big in China
BarronsOnline
7/29/08
Sales
breaches cost Pfizer, Roche, Glaxo
Fierce
Pharma 7/29/08
Takeda
May Post First Loss in 23 Years on Acquisition
Bloomberg
7/29/08
SciClone
narrows Q2 loss on hepatitis drug sales
Bizjournals.com
7/29/08
Alcon
Trades at Lofty Valuation
Yahoo/Zacks.com
7/29/08
Japan
ripe for generics, says Teva chief
FT.com
7/29/08
Vanda
shares plunge on FDA drug rejection
Yahoo/AP
7/29/08
Barr,
Amgen enter drug patent dispute
Yahoo/AP
7/29/08
Alexion
swings to profit as Soliris sales rise
Marketwatch
7/29/08
Inspire
extends study of cystic fibrosis drug
Bizjournals.com
7/29/08
Wake-Up
Call For Minrad
Forbes
7/29/08
BioCryst
shares rise as flu drug hits study goal
Yahoo/AP
7/29/08
|
|
Sanofi
to buy UK vaccine maker Acambis
Forbes
7/28/08
Big
Pharma self-medicates in a bid to lift ailing returns
Guardian,
UK 7/28/08
Pfizer's
Kindler Says He Inherited Inefficient Research Effort
Bloomberg
7/28/08
Roche
faces obstacles in acquiring Genentech
InPharmaTechnologist
7/28/08
Amgen
higher after progress on osteoporosis drug
Marketwatch
7/28/08
Elan,
Wyeth to report midstage data on key Alzheimer's disease treatment
candidate
Yahoo/AP
7/28/08
Pfizer’s
Kindler Decries His ‘Monolithic Structure’
Pharmalot
7/28/08
Novartis'
Exforge more effective than only amlodipine
Reuters,
UK 7/28/08
A
Biotech Bloom in July
Seeking
Alpha 7/28/08
Boning
Up on Amgen’s Rally
WSJ
Online 7/28/08
Glaxo's
Stem-Cell Bet
Forbes
7/28/08
Pfizer
CEO: R&D Needs To Be More Efficient
WSJ
Online 7/28/08
The
Implications of Health-Care Reform
Businessweek
7/28/08
Another
Disappointing Year for Alzheimer’s Drugs
WSJ
Online 7/28/08
Vanda
Pharma Sinks on FDA Rejection
TheStreet.com
7/28/08
Exelixis
hopes for Glaxo licensing payment
Forbes
7/28/08
Swiss
biotech Addex makes first profit,shares rise
Hemscott,
UK 7/28/08
Chugai
Shares Rise After FDA Says Actemra Drug Works
Bloomberg
7/28/08
Nexavar
Approved for Liver Cancer in China
Yahoo
7/28/08
|
|
Drug
Test a Success for Amgen
The
Ledger, FL 7/27/08
Summer
Slump for China Biotech News
Seeking
Alpha 7/27/08
The
State of Statins and Stents
Seeking
Alpha 7/27/08
Dr
Reddy’s Laboratories: Hold
Sify,
India 7/27/08
FDA
Rejection Likely for Biovest
Minyanville
7/27/08
Bristol/Lilly:
The Battle Begins
Forbes
7/25/08
Buyout
or Sellout (Teva/Barr and Roche/Genentech)?
Motley
Fool 7/25/08
Will
Pfizer Pfizzle?
Motley
Fool 7/25/08
Roche's
Big Hurdle with Genentech
Businessweek
7/25/08
Elan
says 2Q sales grow, forecasts MS drug to become $1 billion `blockbuster'
soon
Yahoo/AP
7/25/08
Genentech
Forms Special Committee of Independent Directors to Review Roche
Proposal
Trading
Markets 7/25/08
Turnabout:
Teva
Forbes
7/25/08
Johnson
& Johnson says FDA decision extends Topamax exclusivity by
nearly a year
Yahoo/AP
7/25/08
Pharma
Invests Big in Stem Cells
MIT
Technology Review 7/25/08
Bristol
touts 'great' second-quarter
Star
Ledger, NJ 7/25/08
Pfizer's
Valuation Metrics Show Limited Downside Risk
Seeking
Alpha 7/25/08
Senator
Sends Letter To Merck Over Co's Outsourcing
Easy
Bourse, France 7/25/08
Barr
challenges Cephalon pain-drug patent
Yahoo/AP
7/25/08
Bayer
anticoagulant drug wins EU green light
Reuters
7/25/08
Taro:
Sales Strong Despite Sun Fight
FDA
News 7/25/08
FDA
likely to rule soon on Vanda Pharmaceuticals drug approval
Bizjournals.com
7/25/08
Biotech
stages a "strong comeback"
Yahoo/SmallCapInvestor
7/25/08
GSK
signs transformational agreement with Aspen
Pharmaceutical
Business Review 7/25/08
Watson
Launches Omeprazole Delayed-Release Capsules, 40MG
Trading
Markets 7/25/08
Ziopharm
reports preliminary efficacy data from Phase I cancer trials
Pharmaceutical
Business Review 7/25/08
Rise
in drug prices boosts Medco's profit
Star
Ledger, NJ 7/25/08
|
|
Lilly
profit rises, helped by lower taxes
Reuters
7/24/08
Bristol-Myers
Profit Jumps 23% on Sales of Plavix
Bloomberg
7/24/08
Law
firm sues Roche, calls Genentech bid too low
Boston
Globe, MA 7/24/08
Pfizer
Leans On Lipitor, Cost Cutting
Forbes
7/24/08
Gilead
shares rise as new HIV study begins
Forbes
7/24/08
Witty
unveils three-fold approach for GSK
FT.com
7/24/08
Pfizer,
Wyeth Benefit From Overseas Growth
Harford
Courant, CT 7/24/08
[video]Wyeth
CEO on Earnings
CNBC
7/24/08
Pfizer
Only a Good Hold
Zacks.com
7/24/08
Searching
for the Best Biotech ETF
Seeking
Alpha 7/24/08
ImClone
Hits Profit Target
TheStreet.com
7/24/08
Celgene
earnings per share double in second quarter
Marketwatch
7/24/08
Is
Pfizer's Viagra Suffering with the Economy?
Seeking
Alpha 7/24/08
Wyeth
Test May Reveal False Promise in Alzheimer's
Bloomberg
7/24/08
GSK
continues shift in strategic direction
InPharmaTechnologist
7/24/08
The
Long Case for Abbott Laboratories
Seeking
Alpha 7/24/08
Glaxo
CEO wants broader group, cautious on outlook
US
Daily 7/24/08
Statins
may help kidney transplant patients: study
Reuters
7/24/08
Gene
tied to muscle weakness from cholesterol drugs
Reuters
7/24/08
Astra
seeks approval for diabetes drug
Yahoo/AP
7/24/08
Dynavax
inks flu vaccine deal with Novartis
Bizjournals.com
7/24/08
|
|
Merck
shares way down, Schering recovering
Forbes
7/23/08
Pfizer
Beats EPS Target by a Penny
TheStreet.com
7/23/08
GlaxoSmithKline
earnings hurt by generics, Avandia
Bizjournals
7/23/08
Wyeth
earnings crimped by generic competition
Marketwatch
7/23/08
Merck/Schering-Plough's
Heart Drug Couldn't Have Done Worse
Seeking
Alpha 7/23/08
Teva
completes Bentley Pharmaceuticals acquisition
Boston
Globe, MA 7/23/08
Roche-Genentech
deal could spark worker defections
Hemscott,
UK 7/23/08
Roche
looks to maximize Genentech potential
Trading
Markets 7/23/08
Biotech
Buying Binge About to Begin?
Seeking
Alpha 7/23/08
Amgen
Looking Attractive Heading into Earnings
Seeking
Alpha 7/23/08
Is
pharma's doomsday nigh?
Pharmaceutical
Technology 7/23/08
Viagra
May Ease Sexual Problems of Women on Antidepressants
WSJ
Online 7/23/08
AstraZeneca,
Bristol-Myers submit US and EU application for Onglyza
Trading
Markets 7/23/08
Glaxo
fails to hook investors
Guardian,
UK 7/23/08
Merck
KGaA Net Falls Short on Crystals; Shares Drop
Bloomberg
7/23/08
Did
Merck's Sex and the City Strategy Work?
Seeking
Alpha 7/23/08
Roche
gets Arius in biotech buying moves
Yahoo/AP
7/23/08
Eisai
Victorious Over Teva and Dr. Reddy’s in Aciphex Compound
Patent Case
Seeking
Alpha 7/23/08
Anemic
Amylin's Signs of Recovery
Motley
Fool 7/23/08
Anxiously
Awaiting Exelixis
Motley
Fool 7/23/08
Depomed
drug gets European marketing OK
Bizjournals
7/23/08
MedMira
Wins “Triple Crown” with Rapid Diagnostic Device
Seeking
Alpha 7/23/08
|
|
Another
Blow For Merck And Schering
Forbes
7/22/08
Merck
Beats, but Offers No Forward Guidance
TheStreet.com
7/22/08
Schering-Plough
2Q profit falls on charges
Yahoo/AP
7/22/08
Vytorin
Didn't Slow Progression of Aortic Valve Disease
CNBC
7/22/08
[video]Roche's
Play for DNA
CNBC
7/22/08
Can
Roche Retain Genentech’s Top Talent?
WSJ
Online 7/22/08
Big
Pharma: What Safe Haven?
Businessweek
7/22/08
Roche's
Genentech Offer Sends Ripples Through Biotech
Seeking
Alpha 7/22/08
Forest
Labs' first-quarter profit falls on charge
Marketwatch
7/22/08
Two
Ways To Play: This Is Your Heart On Vytorin
Minyanville
7/22/08
Making
Genentech Disappear
Forbes
7/22/08
Biogen
2nd-quarter profit rises 11 percent
Forbes/Reuters
7/22/08
GlaxoSmithKline
undergoes corporate restructuring
Pharmaceutical
Business Review 7/22/08
Amgen
Rolls the Dice
Motley
Fool 7/22/08
Sanofi
pays $544 mln for Primary's vitamin unit
Reuters,
UK 7/22/08
Flotation
at Elan on cards as strategic review planned
Irish
Independent 7/22/08
Chugai
Pharma First-Half Profit Falls 10% on Tamiflu
Bloomberg
7/22/08
CSL
Shares Slump Most in 5 Years as Vaccine Sales Sag
Bloomberg
7/22/08
Amylin
posts wider second-quarter net loss
Guadian,
UK 7/22/08
Actelion
Q2 profit falls 19 pct, raises forecast
Reuters,
UK 7/22/08
Targacept
Initiates Phase 2b Clinical Trial of TC-5214 as Augmentation Treatment
in Major Depressive Disorder
Trading
Markets 7/22/08
Amarin
Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia
Yahoo
7/22/08
|
|
Roche
Aims to Buy Rest of Genentech for $43.7 Billion
Bloomberg
7/21/08
Merck
and Schering delay 2Q reports to afternoon
Yahoo/AP
7/21/08
Key
Vytorin Results Expected
Forbes
7/21/08
Wall
Street expects higher offer for Genentech
Yahoo/AP
7/21/08
Pfizer
Stock: Value Trap?
Seeking
Alpha 7/21/08
Glaxo
Pays Biota A$20 Million to Settle Relenza Suit
Bloomberg
7/21/08
Roche
Pines For The Rest Of Genentech
Forbes
7/21/08
NH
reps want to get tough with drug manufacturers
Boston
Globe, MA 7/21/08
Biogen
Drug's Steady Return
WSJ
Online 7/21/08
Drugmaker
ills to drive growth, deals in lab sector
Guardian,
UK 7/21/08
Gilead
Sciences: Industry Landscape, Strong Growth Make It a Buy
Seeking
Alpha 7/21/08
Targacept
Initiates Phase 2b Clinical Trial of TC-5214 as Augmentation Treatment
in Major Depressive Disorder
Trading
Markets 7/21/08
Virosome
studied by MedImmune
Life
Scientist 7/21/08
Dr.
Reddy's Profit Falls as Drug Sales Costs Rise
Bloomberg
7/21/08
Novartis
Unit Recalls Prescription Eye Drops As Health Canada Warns Of
Safety Issues
Trading
Markets 7/21/08
|
|
Earnings
Preview: Merck & Co.
Yahoo/AP
7/19/08
Foolish
Forecast: How Quickly Can Merck Turn It Around?
Motley
Fool 7/19/08
Earnings
Preview: Schering-Plough
Yahoo/AP
7/19/08
Teva
and Barr Invites Public to Listen to Webcast
PharmaLive
7/19/08
Weak
U.S. dollar should boost Big Pharma earnings
MarketWatch
7/19/08
Try
J&J's Plan for Healthy Growth
The
Street 7/19/08
Novartis
says pharma sales to pick up in H2 -paper
Reuters
7/19/08
Gilead
shares fall on 2Q report, growth concerns
Yahoo
7/19/08
Still Liking Gilead, Warts and All
Motley
Fool 7/19/08
Zentiva
rejects Sanofi Aventis bid
Yahoo/AP
7/19/08
US test delays hit ProStrakan
The
Scotsman, UK 7/19/08
Drug
Wars
Forbes
7/19/08
The
Marriage of Daiichi Sankyo and Ranbaxy: Where's the Due Diligence?
PharmTech
7/19/08
Will
Teva, The ‘Mighty Israeli PacMan,’ See a Rival Bidder
for Barr Pharma?
Wall
Street Journal 7/19/08
Ranbaxy
blames MNC rival for share price fall
TMCnet
7/19/08
Feuerstein's
Biotech-Stock Mailbag: Synta
The
Street 7/19/08
Invest
in Biovest?
Minyanville
7/19/08
J&J
found not liable in Motrin lawsuit
Yahoo
7/19/08
GTC Biotherapeutics Receives NASDAQ Notice of Non-Compliance
Yahoo
7/19/08
Novartis
unit recalling prescription eye drops
Yahoo
7/19/08
The Multiple Myeloma Research Consortium (MMRC) Announces the
Initiation of Phase I/II Study of Elotuzumab (Huluc63) Monoclonal
Antibody in Combination With Velcade
Red
Orbit 7/19/08
FDA
Special Protocol Assessment (SPA) For Expanded Indication Of LibiGel®
In FSD For Female Sexual Dysfuntion
Medical
News Today 7/19/08
Resverlogix's
Lead Drug Featured in Key Scientific Publication
CNW
Telbec, Canada 7/19/08
Meditrina
wins approval for Phase IIb endometriosis trial
Pharmaceutical
Business Review 7/19/08
NIAID
Cancels HIV Vaccine Trial, but Adds More Focused One
Bioworld
7/19/08
Brain
Illness Drug Market Largely Shunned by Investors
Bioworld
7/19/08
|
|
Novartis
posts 17 percent jump in profit
Star
Ledger, NJ 7/17/08
Pharma
sales undergoes major shift
Fierce
Pharma 7/17/08
Abbott
Labs Attacks Arthritis
Forbes
7/17/08
Merck
to fund Vioxx settlement in August
Yahoo/AP
7/17/08
Teva faces trouble over Copaxone
Pharmaceutical
Business Review 7/17/08
Barr
Rises Most in Almost 8 Years on Teva Speculation
Bloomberg
7/17/08
J&J:
Fairly Priced Core Holding
Yahoo/Zacks.com
7/17/08
Will
Lilly's Survey Have the Desired Effect on Cialis?
Seeking
Alpha 7/17/08
Abbott Proves Successful in a Very Tough Market
Seeking
Alpha 7/17/08
Health
Care ETFs: Drugs and Devices Holding Their Own
Seeking
Alpha 7/17/08
Commentary:
Biotech stocks look technically and fundamentally strong
Marketwatch
7/17/08
Lev
Acquisition Looks Good but More Clarity Needed
Seeking
Alpha 7/17/08
ImClone
shares rise on Erbitux approval in Japan
Forbes
7/17/08
Novartis:Timing Of German Generic Plavix Launch Tough To Call
Easy
Bourse, France 7/17/08
Doribax Called Effective For Pneumonia Strain
CNN
Money 7/17/08
Wyeth
settles patent dispute with Impax Laboratories over generic antidepressant
Yahoo/AP
7/17/08
Cephalon Shares Kept a Hold For Now
Yahoo/Zacks.com
7/17/08
Antisoma says Novartis to expand trial for ASA404, lung cancer
treatment
Hemscott,
UK 7/17/08
|
|
Abbott
reports 34% spike in quarterly profit: diversified healthcare
group raises 2008 forecast
Marketwatch
7/16/08
Genentech
Needs More Profit Power
Motley
Fool 7/16/08
Daiichi
Sankyo to take over Primary Care sales force from Merck KGaA
Trading
Markets 7/16/08
Johnson & Johnson's Future Looks Bright
Seeking
Alpha 7/16/08
PhRMA Note to Pharma: ‘Your House Is On Fire, and You’re
Still Smoking in Bed’
WSJ
Online 7/16/08
In Tough Times, Genentech and J&J Keep Rolling
WSJ
Online 7/16/08
Amgen's Enbrel Drug Works in Early-Stage Arthritis, Study Finds
Bloomberg
7/16/08
Ranbaxy Says Daiichi Accord Is Binding; Shares Surge
Bloomberg
7/16/08
A
(Partial) Comeback for Drug-Coated Stents
WSJ
Online 7/16/08
Statin drug no aid for a learning disability: study
Reuters
7/16/08
Diversification
Pays Off For J&J
Forbes
7/16/08
More
Cuts Across the Board
PharmExec
7/16/08
Strong
Outlook for Regeneron
Trading
Markets 7/16/08
Cardiome
Pharma: More Encouraging Trial Results
Seeking
Alpha 7/16/08
Study Finds Focalin XR Works Quicker Than Concerta
FDA
News 7/16/08
Biogen
Idec shares rise on 2Q Rituxan sales
Forbes
7/16/08
ImClone's Erbitux approved for colorectal cancer in Japan
Marketwatch
7/16/08
ViroPharma Adopts An Orphan Drug
Forbes
7/16/08
Teva, Active Biotech enroll patients in second MS-drug trial
Marketwatch
7/16/08
Pfizer's
Saxton: healthcare professionals must lead CME
Medical
Marketing and Media 7/16/08
Infinity
Pharmaceuticals fall on move to end study; analysts stay focused
on lead program
Yahoo/AP
7/16/08
|
|
J&J
Beats Profit Expectations
The
Street.com 7/15/08
Genentech
ends midstage studies because of anemia risk with Avastin drug
combination
Yahoo/AP
7/15/08
Drug
prevents bone loss in prostate cancer: Amgen
Reuters
7/15/08
Will
a New Use Help Schering-Plough's Near-Blockbuster Drug?
Motley
Fool 7/15/08
Abbott
Laboratories expected to post solid 2nd-quarter results on drug,
medical device sales
Yahoo/AP
7/15/08
Genentech,
J&J boost drug sector
Marketwatch
7/15/08
Genentech Results No Cure For Anxiety
Yahoo/Minyanville
7/15/08
A
Fat Yield at Pfizer
Seeking
Alpha 7/15/08
[video]Cramer:
Pick a Pharma Now
TheStreet.com
7/15/08
Schering
upgraded as analyst expects strong profit and sales growth over
next 5 years
Yahoo/AP
7/15/08
Amgen,
J&J Come To Truce in Oncology Marketing Suit
WSJ
Online 7/15/08
Prosecutors
allege Indian drug maker Ranbaxy Laboratories forged documents
submitted to FDA
Yahoo/AP
7/15/08
Questions
About Long-Term Use of Bone Drugs
NY
Times, NY 7/15/08
Two Ways To Play: Genentech's Good Genes
Minyanville
7/15/08
US Senate widens psychiatry/pharma funding probe
PharmaTimes,
UK 7/15/08
Wyeth:
N.J. judge dismisses two hormone therapy lawsuits
Marketwatch
7/15/08
Cephalon
drug prompts response in cancer study
Yahoo/AP
7/15/08
Cardiome Gets Hearts Racing
Forbes
7/15/08
ViroPharma
to buy Lev Pharma for $443 million
Marketwatch
7/15/08
Allos Therapeutics Looks Promising Ahead of Crucial 6 Months
Seeking
Alpha 7/15/08
Infinity
Halts Prostate Cancer Drug Study
WSJ
Online 7/15/08
|
|
GSK
to pay Actelion up to $3.3 bln for insomnia drug rights
Yahoo/Reuters
7/14/08
Eli
Lilly: Good Dividend but Is the Stock Worth the Risk?
Seeking
Alpha 7/14/08
Amgen,
Genzyme lead drug stocks higher
Marketwatch
7/14/08
Wall
Street expects quiet quarter for Johnson & Johnson as it builds
pipeline, cuts costs
Yahoo/AP
7/14/08
Pharma
gains from market turmoil, but for how long
Forbes/Reuters
7/14/08
Amgen
Announces Positive Top-Line Results for Denosumab Treatment of
Bone Loss in Men With Non-Metastatic Prostate Cancer Undergoing
Androgen Deprivation Therapy
Marketwatch
7/14/08
Teva comes out fighting as generic Copaxone is filed
PharmaTimes,
UK 7/14/08
FDA
questions testing of J&J pneumonia antibiotic
Yahoo/AP
7/14/08
India's Ranbaxy Challenged by U.S. on Generic Drugs
Bloomberg
7/14/08
Roche
to Stop Research Projects on Experimental HIV Treatments
Bloomberg
7/14/08
Summary
Judgment in Seroquel Case Favors AstraZeneca; Teva and Sandoz
to Appeal
Seeking
Alpha 7/14/08
Myriad’s
failure in Alzheimer’s causes industry to rethink amyloid
hypothesis
FT.com
7/14/08
Immunogen's
Wild Swings Due to Lack of Information at ASCO
Seeking
Alpha 7/14/08
Neurogen
pauses trial of insomnia drug candidate adipiplon because of next-day
effects
Yahoo/AP
7/14/08
Cardiome
Announces Positive Phase 2b Results For Oral Vernakalant
Yahoo
7/14/08
Allergan Completes Acquisition of Aczone Gel 5%
Yahoo
7/14/08
Proximagen
Rises Most in 12 Months on Licensing Deal
Bloomberg
7/14/08
FDA
Accepts Genta's NDA Amendment as Complete Response for Genasense(R)
Treatment of Chronic Lymphocytic Leukemia
Yahoo
7/14/08
|
|
AstraZeneca:
Size, Safety and Consistency
Seeking
Alpha 7/13/08
China
Biotech Weekly Review
Seeking Alpha 7/13/08
Amgen
and Ortho Biotech Settle Antitrust Suit
Yahoo 7/13/08
Commonwealth
Biotech Invests in Venturepharm JV
Seeking
Alpha 7/13/08
US
sues Ranbaxy for forging data
MSN
India, India 7/13/08
Alnylam
shares fall on Europe patent dispute loss
Yahoo/AP
7/13/08
Teva
drags TASE lower
Globes,
Israel 7/13/08
Getting
Technical With Biotech (GENZ, GILD, ILMN)
Investopedia
7/13/08
Pharma
alliances, a shot in the arm
Sify,
India 7/13/08
Lilly
Partners With the National Council of La Raza to Fight Chronic
Disease
PR
Newswire 7/13/08
|
|
[video]Genentech:
Test for Biotech
CNBC
7/11/08
Zentiva
Says Will Comment On Sanofi's Takeover Bid
CNN
Money 7/11/08
FDA Told to Skip ‘Black Box’ on Epilepsy Drugs and Suicide
WSJ
Online 7/11/08
Elan In Double Trouble?
CNBC
7/11/08
US
to review Momenta's generic of Teva's Copaxone
Reuters,
UK 7/11/08
Merck receives European approval, covering 29 nations, for its
cholesterol drug Tredaptive
Yahoo/AP
7/11/08
Lighting
A Path To Drug Discovery
Forbes
7/11/08
Roche
May Boost Tamiflu Sales After Tests Deny Psychiatric Link
Bloomberg
7/11/08
Roche/Sanofi Malaria Drug Lowers Anemia, Improves Attention Span
in Children
Bloomberg
7/11/08
Suit
alleges Chantix led to suicide
The
Day, CT 7/11/08
Schering's
Pegintron cuts melanoma return risk-study
Reuters,
UK 7/11/08
The
next Viagra
Investors
Chronicle, UK 7/11/08
Novartis and Lonza partner in biologics development
Trading
Markets 7/11/08
Drug marketing code draws line at gift pens
Reuters,
UK 7/11/08
Japan finds no Tamiflu link to abnormal behavior
National
Post 7/11/08
No
Relief in Sight for MannKind
Yahoo/Zacks.com
7/11/08
BioMedica plunges as cancer drug trial disappoints
Reuters
7/11/08
Aura
Biosciences: a tiny cure for cancer?
CNN
Money/Fortune 7/11/08
Oxford Biomedica's phase III trial for cancer jab Trovax 'will
not meet goals'
Hemscott,
UK 7/11/08
|
|
FDA
Panel To Consider Suicide Risks Of Epilepsy Drugs, Pfizer Defends
Safety Of Lyrica
Trading
Markets 7/10/08
New
pharma ethics rules eliminate gifts and meals
Boston
Globe, MA 7/10/08
Speedel
Ahead On Novartis Deal
Forbes
7/10/08
Pfizer
disputes suicide risks with epilepsy drugs
Yahoo/AP
7/10/08
Analysts: Novartis' buyout of Speedel and gain of blood-pressure
drug positive strategic moves
Yahoo/AP
7/10/08
Pfizer,
Merck And Lilly Partner Up To Get "Enlightened"
CNBC
7/10/08
Slimming Down at GlaxoSmithKline, One Molecule at a Time
WSJ
Online 7/10/08
Industry Insider: Vytorin's 2nd chance to prove strength
Star
Ledger, NJ 7/10/08
Biotech
Notebook: Vertex, Medarex
TheStreet.com
7/10/08
Incyte
Getting Boost from Pfizer
Yahoo/Zacks.com
7/10/08
The
Vytorin Stretch
Forbes
7/10/08
Clinical
Hold on Dynavax Drug
Yahoo/Zacks.com
7/10/08
Merck
Serono: Erbitux(R) Phase III Clinical Study In Gastric Cancer
Started
Medical
News Today, UK 7/10/08
Status
Report: APP Pharmaceuticals - Fresenius
Seeking
Alpha 7/10/08
MedImmune
wins $28.4M flu vaccine contract
Bizjournals.com
7/10/08
Roche
and Allergan Victorious Over Apotex in Acular LS Dispute
Seeking
Alpha 7/10/08
Another
acquisition for Veeda Oncology
PharmaTimes,
UK 7/10/08
BioCryst
to conduct another clinical trial of flu drug
Bizjournals.com
7/10/08
Staying
Neutral on Arena Pharma
Yahoo/Zacks.com
7/10/08
Actavis
generic prostate cancer drug Bicalutamide first to market in UK,
Germany, France
PharmaLive
7/10/08
|
|
Lilly
Will Buy SGX Pharmaceuticals for $64 Million
Bloomberg
7/9/08
Big
Pharma Stocks: Real Rally Or One Day Wonder?
CNBC
7/9/08
Euro
drugmakers in lead for third straight session
Marketwatch
7/9/08
Merck,
Schering-Plough climb on Vytorin speculation
Marketwatch
7/9/08
Antibiotics
can harm tendons, FDA warns
Reuters
7/9/08
AstraZeneca
wins admirers
Investors
Chronicle 7/9/08
Pharma's exodus begins
Star
Ledger, NJ 7/9/08
Hormone Therapy Fails to Help Early Prostate Cancer
Bloomberg
7/9/08
Big
Pharma & Big Government = Big Profits?
Genetic
Engineering News 7/9/08
Drugs'
Links To Suicide Risk
Draw Concern
WSJ
Online 7/9/08
Death
of a Euphemism: The End of FDA’s ‘Approvable Letter’
WSJ
Online 7/9/08
Merck responds to Gardasil safety questions
Hays
Pharma 7/9/08
Blockbuster
Drugs Bound for Extinction?
Motley
Fool 7/9/08
Novartis
Finds Defense in Alcon
TheStreet.com
7/9/08
Johnson
& Johnson shifting 260 jobs to Centocor
Bizjournals.com
7/9/08
Bristol-Myers
Squibb agrees to Clean Air Act upgrades
Trading
Markets 7/9/08
Soliris the "Go-To" Drug for Alexion
Yahoo/Zacks.com
7/9/08
Merck
KGaA starts Phase III study of Erbitux on gastric cancer
Forbes
7/9/08
Arena
Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results
of APD791 for the Treatment of Arterial Thrombosis
Yahoo
7/9/08
|
|
Genentech
shares drop on renewed Rituxan concerns
Reuters
7/8/08
Merck
stock dips as analyst predicts flat Gardasil sales
PharmaTimes,
UK 7/8/08
Novartis closer to $38B Alcon takeover
SF
Gate, CA 7/8/08
Does
All of Pfizer's Bad News Just Have To Be In by Now?
SeekingAlpha
7/8/08
Antidepressants tied to gastrointestinal bleeding
Reuters
UK 7/8/08
LifeCycle
Says its Tacro Transplant Drug Betters Astellas's
Bloomberg
7/8/08
Pricey Drugs Put Squeeze on Doctors
WSJ
Online 7/8/08
And
Then There Were 4(drug stent market)
Motley
Fool 7/8/08
Shire May Have Another Winner in Purchase of Jerini
Seeking
Alpha 7/8/08
Ahead
of the Bell: Teva shares edge up
MSN
Money 7/8/08
Health
Winners & Losers: Teva
The
Street.com 7/8/08
Generics?
No Thanks, We’re Glaxo
WSJ
Online 7/8/08
Win
With Genentech Against the Bears
CNBC
7/8/08
Trade
idea for Merck (MRK) downgrade
Blogging
Stocks 7/8/08
The
Bi-Polar Biotech Market Will Continue
Seeking
Alpha 7/8/08
Noven
Pharma falls after analyst cuts rating
Forbes
7/8/08
Cardinal Health Will Cut 600 Jobs in Consolidation
Bloomberg
7/8/08
Stiefel
Labs offering $4.15 a share for Barrier Therapeutics
Marketwatch
7/8/08
Blow
for GSK’s breast cancer drug
Ft.com
7/8/08
FDA
Still Mulling Warning for Pfizer’s Lyrica
WSJ
Online 7/8/08
GlaxoSmithKline:
Cervarix Gets Reimbursement OK In France
CNN
Money 7/8/08
Schering-Plough
follicle stimulant meets Phase-III endpoint
Marketwatch
7/8/08
Cowen's "Elan" For Elan
CNBC
7/8/08
SkyePharma
Has Record Drop After Suspending Bond Plan
Bloomberg
7/8/08
Medivation
drug improves Huntington's
Reuters
7/8/08
|
|
Novartis
(NVS): Big Pharma's best pipeline
Blogging
Stocks 7/7/08
Merck,
Teva lead losing session for pharma issues
Marketwatch
7/7/08
Pediatricians
say some kids should take statins
Fierce
Pharma 7/7/08
Patients
More Likely to Stay on Lipitor Than Simvastatin, a Large Observational
Study Shows
Yahoo
7/7/08
[video]Biopharma
Stocks on the Move
CNBC
7/7/08
Is
Avastin really worth the cost?
Fierce
Pharma 7/7/08
U.K.
Says Glaxo’s Breast Cancer Drug Isn’t Worth the Money
WSJ
Online 7/7/08
Glaxo Seeks Guidance
From Health Systems
WSJ
Online 7/7/08
Biopure
plans blood substitute study
Yahoo/AP
7/7/08
Biotech stocks open mixed as the broader market rises in face
of falling oil prices
Yahoo/AP
7/7/08
Survey:
Pharma tries "selling outcomes"
Fierce
Pharma 7/7/08
Teva
Provides Update on Forte Trial
PharmaLive
7/7/08
APP
Pharmaceuticals shares skyrocket after Fresenius moves in for
$3.7 billion cash buyout
Yahoo/AP
7/7/08
Pfizer's
Prospects: Just Ducky
Corante
7/7/08
US
FDA to urge black box warning for epilepsy drugs
Reuters
7/7/08
Biotech
stocks open mixed as the broader market rises in face of falling
oil prices
Yahoo/AP
7/7/08
|
|
Judge
urges Eli Lilly to settle Zyprexa lawsuit
Indianapolis
Business Journal, IN 7/6/08
Cytori
Therapeutics: The Stem Cell 'Celution' for Success
Seeking
Alpha 7/6/08
Price
for Teva to buy Bentley drops
Globes,
Israel 7/6/08
Dr
Reddy`s may miss sales forecast, say analysts
Business Standard, India 7/6/08
Teva
Tech employees want one thing
Globes,
Israel 7/6/08
Biotech-Stock
Mailbag: Amgen, MiddleBrook
The
Street 7/5/08
Why
did Ranbaxy promoters exit?
Economic
Times, India 7/5/08
Bayer
and Titan: Spheramine cell therapy discontinued
Pharmaceutlcal
Business Review 7/5/08
Wyeth
and Progenics win European approval for constipation drug
Pharmaceutlcal
Business Review 7/5/08
Bentley
Pharmaceuticals Inc to be acquired by Teva Pharmaceutical Industries
Ltd
Trading
Markets 7/5/08
Patent-obsessed big pharma joining hands with generics competitors
Economic
Times, India 7/5/08
Pfizer
terminates funding for CME programs run by MECCs
Pharmaceutlcal
Business Review 7/5/08
Revised
Study Maintains Link Between FDA Approvals Made Soon Before Deadlines,
Safety Risks
Medical
News Today 7/5/08
Amgen
Diminished Shares Poised to Rebound on `Savior' Bone Drug
Bloomberg
7/3/08
Pfizer Stops Funding Some Classes for Doctors
WSJ
Online 7/3/08
Palatin
and AstraZeneca expand obesity collaboration
Pharmaceutical
Business Review 7/3/08
Private
Sector Driving Pharma R&D, Finds Study
Red
Orbit 7/3/08
Pfizer
Employees Brace Themselves
Seeking
Alpha 7/3/08
Amgen's
Experimental Drug May Slow Thyroid Cancer, Study Finds
Bloomberg
7/3/08
FDA
Approves J&J's Collagen Facial Filler
WSJ
Online 7/3/08
Pfizer's
spun-off Japan lab targets IPO by 2011
Reuters
7/3/08
Genentech Increasing Push Into Big Pharma's Research Turf
CNN
Money 7/3/08
Lilly
Loses Appeal to Limit Damages in Canadian Suit
Bloomberg
7/3/08
[video]Stent
Wars Escalate
CNBC
7/3/08
Glaxo
Scientist's `Aha' May Yield Malaria Vaccine
Bloomberg
7/3/08
Shire
to acquire biotechnology company Jerini for 328 million euros
Forbes
7/3/08
Daiichi Sankyo Reaches 3-Month High on Merrill `Buy'
Bloomberg
7/3/08
Skyepharma
Up On Third Positive Flutiform Study
CNN
Money 7/3/08
Eisai
wins approval for GERD drug
Pharmaceutical
Business Review 7/3/08
FDA
lifts clinical hold on Adolor bowel drug
Yahoo/AP
7/3/08
Illumina shares reach record high as analysts reaffirm positive
sales outlook
Yahoo/AP
7/3/08
Anika
Therapeutics: Building On Previous Success
Seeking
Alpha 7/3/08
Repros
initiates Phase IIb study of oral male fertility drug
Pharmaceutical
Business Review 7/3/08
|
|
AstraZeneca
shares jump 6 percent after US court win on Seroquel patent fight
Yahoo/AP
7/2/08
Pharmaceuticals open mostly higher as broader market advances
ahead of factory order report
Yahoo/AP
7/2/08
Exelixis
and Glaxo Begin Their Goodbyes
Motley
Fool 7/2/08
Myriad's
Small Billion-Dollar Loss
Motley
Fool 7/2/08
FOCUS
Investors may have overestimated AstraZeneca's Seroquel patent
risk
Trading
Markets 7/2/08
Novartis
`Gold Mine' Shot May Stop Killer Meningitis
Bloomberg
7/2/08
Teva
Granted Final Approval of Risperidone ANDA; Launches with 180-Day
Exclusivity
Seeking
Alpha 7/2/08
SuperGen
Bust a Boon for Celgene
TheStreet.com
7/2/08
The
Lure Of Biotech Stocks
Newsweek
7/2/08
Cubist
Pharma to promote AstraZeneca antibiotic in U.S.
Marketwatch
7/2/08
FDA News Gives Glaxo a Glimmer of Hope
Motley
Fool 7/2/08
Roche
CEO Won’t Shy Away from Primary-Care Drugs
WSJ
Online 7/2/08
Ahead
of the Bell: Biogen Idec
MSN
Money 7/2/08
Leerink
Analyst: Unit sale could benefit J&J
Yahoo/AP
7/2/08
Amgen Falls Into the Bargain Bin
Barron's
7/2/08
Celgene
rises as rival SuperGen's bone marrow cancer drug fails late stage
European study
Yahoo/AP
7/2/08
Merck
KGaA Falls Most Since January on Morgan Stanley Downgrade
Bloomberg
7/2/08
Novartis and GSK to appeal Alabama price-fixing damages
PharmaTimes,
UK 7/2/08
Is
3SBio Too Conservative to Move Forward?
Seeking
Alpha 7/2/08
CoLucid
ready on migraine drug
News
and Observer, NC 7/2/08
Health
Winners & Losers: Halozyme
TheStreet.com
7/2/08
Glenmark
Pharma Buys 7 Actavis Brands in Poland to Enter Market
Bloomberg
7/2/08
|
|
Merck
tops Dow indus. gainers; JPMorgan ups Gardasil outlook
Forbes
7/1/08
Analysts: Key Genentech drug could top 2Q forecast
Forbes/AP
7/1/08
Wyeth and Takeda introduce new formulation of arthritis drug
Pharmaceutical
Business Review 7/1/08
Merck
Experimental Migraine Drug Proves Better Than Zomag In Late-Stage
Study
Trading
Markets 7/1/08
FDA reconsiders diabetes drugs
Forbes
7/1/08
GSK: Diet pills need FDA scrutiny
Fierce
Pharma 7/1/08
Teva
Pharmaceutical Begins to Ship Generic Schizophrenia Drug
WSJ
Online 7/1/08
Abbott
Labs invests $20M in Isis Pharma unit Ibis
Yahoo/AP
7/1/08
Pfizer Cuts Costs by Outsourcing Drug Distribution in China
Seeking
Alpha 7/1/08
Lilly
settles discrimination suit for $64,400
Indianapolis
Star, IN 7/1/08
Sinovac
Starts Phase II Trial of Pandemic Flu Vaccine
Seeking
Alpha 7/1/08
FDA
approves Animas wireless insulin pump system
Bizjournals
7/1/08
NovaMed
Will Market Six Cancer Drugs in China for Pfizer
iStockAnalyst
7/1/08
Palatin
Technologies Announces Amendment Expanding AstraZeneca Obesity
Collaboration
iStockAnalyst
7/1/08
Myriad
Drug Fails
To Fight Alzheimer's
WSJ
Online 7/1/08
Myriad
Genetics: I Told You So
Seeking
Alpha 7/1/08
What's
the Story on Amgen Shorts?
Seeking
Alpha 7/1/08
J&J
receives offer for wound care business
Marketwatch
7/1/08
Baxter
International Hiding in Plain Sight
TheStreet.com
7/1/08
ChemGenex
Shares Climb to 8-Month High on Application
Bloomberg
7/1/08
Celera
separates from Applera
Trading
Markets 7/1/08
|
|
For
Lilly, Cymbalta means new revenue without a new pill. Experts
wonder if profits come at the expense of innovation
Indianapolis
Star, IN 6/30/08
A
Drug to End Merck's Headache?
Motley
Fool 6/30/08
As FDA Focuses on Safety, Fewer New Drugs Are Approved
WSJ
Online 6/30/08
AstraZeneca's Acquisition of MedImmune Still Looks Overpriced
Seeking
Alpha 6/30/08
Under
pressure, pharma collects new indications
Seeking
Alpha 6/30/08
J&J's
Concerta approved for adults, golimumab filed in USA
PharmaTimes,
UK 6/30/08
PDI Announces $33 Million Contract Extension and Expansion with
Top-Five Pharmaceutical Company
Businesswire
6/30/08
Drugmaker
GSK seeks more over the counter regulation
Newark
Star Ledger, NJ 6/30/08
GlaxoSmithKline
Responds to FDA on CERVARIX(R) and Plans to Submit Final Study
Data for Approval
Yahoo
6/30/08
Merck
withdraws Singulair/Claritin combo; telcagepant data impresses
PharmaTimes,
UK 6/30/08
A "Short" Story On Amgen
CNBC
6/30/08
Merck
says odanacatib decreases measures of bone turnover in women with
breast cancer
RTT
News 6/30/08
Teva
multiple sclerosis drug meets goal in mid-stage trial, Antisense
to get $4M payment
Yahoo/AP
6/30/08
Watson
Launches Generic MARINOL(R) Capsules
iStockAnalyst
6/30/08
Myriad,
Lundbeck Alzheimer's drug fails key study
Reuters,
UK 6/30/08
Depomed
gets $15M loan for hot flash program
Bizjournals
6/30/08
U.S.
FDA approves Pfizer injectable pet antibiotic
Reuters,
UK 6/30/08
Sangamo
technology demonstrates ability to make genes resistant to HIV
virus
Yahoo/AP
6/30/08
Indevus
Receives Approvable Letter from FDA for NEBIDO(R)
Yahoo
6/30/08
|
|
Pfizer:
Ride or Let Slide?
Seeking
Alpha 6/29/08
Drugmaker
seeks more over the counter regulation
The
Star Ledger, NJ 6/29/08
UCB's
VimpatTM Recommended For Approval In Europe For Epilepsy
Medical
News Today 6/29/08
MAP
Pharmaceuticals announces positive data for migraine product candidate
RTT
News 6/29/08
Cipla, AIDS groups oppose Roche`s AIDS drug patent in India
Topnews.in,
India 6/29/08
Boston
Scientific Bundles Stents with Defibrillators and Ultrasound
Seeking
Alpha 6/29/08
Drugmakers:
Not So Recession-Proof?
Motley
Fool 6/28/08
American
Technology Research Initiates Coverage On Pfizer (PFE) With A
Buy
Street
Insider 6/28/08
This
Drug Market Is Booming
Motley
Fool 6/28/08
Feuerstein's
Biotech-Stock Mailbag: Delcath
The
Street 6/28/08
Clarification:
Amgen-Denosumab story
Yahoo
6/28/08
Insider
trading: Are Ranbaxy-Daiichi in the clear?
MoneyControl,
India 6/28/08
Will
someone swallow Bristol-Myers?
The
Deal 6/28/08
‘Positive
opinion’ helps ProStrakan shares to soar
The
Herald, UK 6/28/08
Push
for more HIV screens to drive Gilead's growth
Yahoo/AP
6/28/08
Pfizer
Invests $3M in Startup to Advance Stem Cell Therapy
San
Diego Business Journal, CA 6/28/08
Sanofi
sees global vaccine sales doubling: report
Boston
Globe, MA 6/28/08
OSI
shares rise on Weisel "Overweight" rating
Yahoo/AP
6/28/08
Barr
shares rise on Mirapex patent case victory
Yahoo/AP
6/28/08
Why
are Investors so Pessimistic on Uptrending Alexion Pharmaceuticals?
Schaeffers
Research 6/28/08
OSS
Capital Doubles Stake in Par Pharmaceutical (PRX)
Street
Insider 6/28/08
Vanda's
Drug Draws a Yawn
Motley Fool 6/28/08
`Our
economic rationale for Taro remains intact`
Business
Standard, India 6/28/08
Melnyk's actions with Biovial will only 'delay the inevitable'
National
Post, Canada 6/28/08
FDA
Ponders Requiring Heart Studies for Diabetes Drugs
Wall
Street Journal 6/28/08
FDA
Approves CONCERTA (methylphenidate HCI) Extended-release Tablets
finchannel
6/28/08
GlaxoSmithKline's
(GSK) Treximet(TM) Returns Promising New Data
Street
Insider 6/28/08
Merck's
Investigational Migraine Treatment Telcagepant Improved Pain and
Migraine-Associated Symptoms in Phase III Study
Fox
Business News 6/28/08
Centocor
seeks OK for new arthritis drug
Bizjournals
6/28/08
Avalon
Pharmaceuticals Names Lead Development Candidate In Beta-Catenin
Inhibitor Program
Medical
News Today 6/28/08
Dako
Enters into Collaboration with Bristol-Myers Squibb for Pharmacodiagnostics
Fox
Business News 6/28/08
Doctors
complain about increasing reliance on generics
USA
Today 6/28/08
|
|
Study
shows 150 percent jump in statin use
Reuters
6/26/08
Sanofi
launches $6.25bn vaccine battle plan
Outsourcing
Pharma 6/26/08
Merck's
Januvia Set for $4.5 Billion Sales Rejuvenating Shares
Bloomberg
6/26/08
Biotech
Exhibiting a Quiet Strength
Zacks.com
6/26/08
Has
the Storm Passed for Pharma Stocks?
WSJ
Online 6/26/08
Evidence
piles up in support of Bayer/J&J's rivaroxaban
PharmaTimes,
UK 6/26/08
Sanofi
Warrants Cheaper Valuation
Yahoo/Zacks.com
6/26/08
Why
the Lilly Delay, FDA?
Motley
Fool 6/26/08
FDA Delivers One-Two Punch to Merck & Eli Lilly
Seeking
Alpha 6/26/08
Sanofi-Aventis,
Zentiva management end shareholder agreement
Forbes
6/27/08
Bristol-Myers
Squibb Completes Tender Offer for Kosan Biosciences Incorporated
Yahoo
6/26/08
Mixed news for Merck on its RotaTeq and Gardasil vaccines
PharmaTimes,
UK 6/26/08
Terminally
Ill Kids Get `Chance' of Cancer Cure From Wyeth Drug
Bloomberg
6/26/08
Sector
Wrap: Big Pharma no longer a smart investment choice?
Forbes/AP
6/27/08
South Korean court rules against Pfizer in patent dispute
Forbes
6/27/08
Bayer/Barr:
An Even More Complicated Patent Settlement
Motley
Fool 6/27/08
Vanda
insomnia drug tasimelteon meets late-stage trial goal; shares
rise in premarket trading
Yahoo/AP
6/26/08
Why
I'm Cutting WuXi Pharma Position Sharply
Seeking
Alpha 6/26/08
Strong
Isis Pharma Outlook
Yahoo/Zacks.com
6/26/08
Failure Sets Replidyne Back
Yahoo/Zacks.com
6/26/08
Sun Pharma Seeks to Force Taro's Founding Shareholders to Sell
Bloomberg
6/26/08
|
|
Merck
gets response on Gardasil from FDA
Marketwatch
6/25/08
Analyst
says Merck and Schering are in best position to deal with threats
to big pharma
Yahoo/AP
6/25/08
Investor
Focus: Biotech's 2Q winners and losers
Forbes
6/25/08
Amgen, Pfizer Top 2007 U.S. Drug-Lobbyist List, Watchdog Says
Bloomberg
6/25/08
Glaxo Boosts Marketing of Smoking Aids Amid Pfizer Pill's Woes
Bloomberg
6/25/08
Sector
Snap: Biotech _ large-cap or small-cap?
Forbes
6/25/08
Glaxo
Now at Reasonable Value
Zacks.com
6/25/08
Allergan
Premium Makes It a Hold
Yahoo/Zacks.com
6/25/08
Troubles
With Lilly's Effient Empire
SeekingAlpha
6/25/08
Bayer,
J&J's Xarelto Beats Sanofi's Anti-Clotting Drug in Study
Bloomberg
6/25/08
Controversial
obesity drug gets UK okay
Reuters
6/25/08
Roche
says sugar technology has anticancer promise
Reuters
6/25/08
Japan's
Takeda Pharmaceutical's 'Aa1' issuer rating confirmed - Moody's
Hemscott,
UK 6/25/08
Talecris
pumps itself up
News
and Observer, NC 6/25/08
Melnyk
appears to have lost Biovail proxy battle
Vancouver
Sun, Canada 6/25/08
Sciele
and Novo Nordisk granted approval for diabetes drug
Pharmaceutical
Business Review 6/25/08
Melior
options diabetes drug rights to Pfizer
Bizjournals
6/25/08
Study
Might Ease Stent Fears
WSJ
Online 6/25/08
Genmab
initiates zalutumumab Phase I/II trial for head and neck cancer
Pharmaceutical
Business Review 6/25/08
UCB reports positive results from Phase IIa fibromyalgia trial
Pharmaceutical
Business Review 6/25/08
UK
health watchdog recommends Abbott's Humira for psoriasis if other
drugs fail
Forbes
6/25/08
Boehringer receives approval for new Aptivus oral solution
Pharmaceutical
Business Review 6/25/08
|
|
Lilly,
Daiichi blood-thinning drug faces FDA delay
Forbes/Reuters
6/24/08
As FDA Delays Ruling on Eli Lilly Drug, Clock Ticks on Plavix
Patent
WSJ
Online 6/24/08
Merck Migraine Drug Comparable To AstraZeneca Drug In Study
CNN
Money 6/24/08
FDA
Sets a Higher Standard for Merck
Motley
Fool 6/24/08
Vytorin Stabilizing?
Forbes
6/24/08
Pfizer Makes a Deal, Wyeth and Elan Release Alzheimer's Drug Results
Seeking
Alpha 6/24/08
Sanofi
Goes East to Find Growth
Motley
Fool 6/24/08
Pfizer
Pfizzle
Fortune
6/24/08
Bayer, Barr Sign Contract Allowing Generic Yasmin
Bloomberg
6/24/08
Amylin
Has Yet to Crack Tough Diabetes Market
Seeking
Alpha 6/24/08
AstraZeneca
Should Clear Hurdles
Trading
Markets 6/24/08
Will
Bayer AG Overtake AstraZeneca in China Drug Sales?
Seeking
Alpha 6/24/08
Health
Winners & Losers: Barrier Therapeutics
TheStreet.com
6/24/08
FDA
OKs Wider Use of Velcade
TheStreet.com
6/24/08
Novartis
to Work on Joint Development of New Tuberculosis Drugs
Bloomberg
6/24/08
Pfizer
pays the price for clean air violation in USA
PharmaTimes,
UK 6/24/08
Wait a Little Longer, Ligand
Motley
Fool 6/24/08
ImmunoGen
Snapped Up By Ziff
Forbes
6/24/08
'Lost'
Patients Whack BioMarin Shares
TheStreet.com
6/24/08
Vertex
Investors Balk at New Telaprevir Study Plans
TheStreet.com
6/24/08
Emisphere
shares jump on Novo Nordisk deal
Forbes/AP
6/24/08
Akesis Pharmaceuticals and Charles River Laboratories to Begin
13-Week Animal Study for AKP- 020
Yahoo
6/24/08
|
|
Lilly
Awaits FDA Ruling on Key Drug
WSJ
Online 6/23/08
FDA
Stings Pharma, Big and Small
SeekingAlpha
6/23/08
Merck/Schering
Cholesterol Drug Prescrptns Down 1.1% In May
Easy
Bourse, France 6/23/08
Pfizer
Eyes New Use For Stem Cells
Forbes
6/23/08
Leukemia pill may improve stroke treatment: study
Reuters
6/23/08
Sanofi's
Pentacel to compete with GSK's five-in-one jab in USA
PharmaTimes,
UK 6/23/08
Novartis May Start Human Trials of Dengue Treatment Next Year
Bloomberg
6/23/08
Biotech stocks open mostly higher with market rising as investors
look to recover losses
Yahoo/AP
6/23/08
Cancer-fighter
Immunogen raises about $24 million
Bizjournals
6/23/08
Ahead
of the Bell: Acorda Therapeutics downgraded
Yahoo/AP
6/23/08
An Interview With Cleveland BioLabs CEO Michael Fonstein
SeekingAlpha
6/23/08
Warner
Chilcott gets FDA approval to market 150 mg dose of delayed-release
acne pill Doryx
Yahoo/AP
6/23/08
Ranbaxy
to acquire more firms despite change in ownership
Trading
Markets 6/23/08
Barrier
Therapeutics to Merge Into Stiefel Laboratories
Yahoo
6/23/08
FDA Lifts Clinical Hold on Genta's Tesetaxel, a Leading Oral Taxane
Yahoo
6/23/08
Gilead ends HCV research collaboration with Genelabs
Bizjournals
6/23/08
Taro
Receives Final FDA Approval for RX Cetirizine Hydrochloride Syrup
ANDA
PharmaLive
6/23/08
|
|
Mannkind:
Overlooked Biotech With Excellent Prospects
Seeking
Alpha 6/22/08
King
Pharmaceuticals Gets Positive Initial Results On New Drug
Tri
Cities, TN 6/22/08
Now,
Ranbaxy seeks peace with Takeda
Business Times, India 6/22/08
Immtech Pharma to Start JV with Beijing Capital Medical University
Seeking
Alpha 6/22/08
Malvinder
wants to transform Ranbaxy
Hindustan
Times, India 6/22/08
Teva's
Multiple Sclerosis Drug Slows The Disease
emaxhealth
6/22/08
Published
Study Reveals Next Pharmaceuticals' Flavoxine™ Reduces Multiple
Heart Health Risk Factors Including High Cholesterol
Medical
News Today 6/22/08
Big
Pharma’s Big Slump
Wall
Street Journal 6/21/08
A
lengthy delay for Merck medicine
The
Star Ledger, NJ 6/21/08
GlaxoSmithKline:
FDA extends priority review period for Promacta
Trading
Markets 6/21/08
Lilly
Declares Third-Quarter Dividend
Trading Markets 6/21/08
Wyeth's
Long-Term Potential
Yahoo/Zacks
6/21/08
Ranbaxy
will continue acquisition, says CEO
Times
of India, India 6/21/08
Biovail
Provides Shareholders With Additional Analyst Commentary
Welt
Online, Germany 6/21/08
FDA
lifts clinical hold on YM BioSciences's pain drug
Pharmaceutical
Business Review 6/21/08
Takeda
wins US OK for expanded Velcade use
Reuters
6/21/08
Trubion
says Wyeth extends research collaboration
Yahoo
6/21/08
New
Data Show Merck's Rotateq Helped Reduce Hospitalizations and Emergency
Room Visits Due to Rotavirus Gastroenteritis for up to Three Years
after Vaccination
PharmaLive
6/21/08
Live
From Bio: Personalized Medicine
Motley
Fool 6/21/08
Senator
asks FDA to investigate pharmaceutical outsourcing
Smart
Brief 6/21/08
MGI
Pharma done at yearend
Pioneer
Press, MN 6/21/08
|
|
Pfizer
Settles Lipitor Patent Dispute With Ranbaxy, Delays Launch Of
Generic Version
Trading
Markets 6/19/08
Biogen
Idec wins proxy fight against Icahn
Yahoo/Reuters
6/19/08
Where Will Pfizer Spend Cash?
Yahoo/Zacks.com
6/19/08
FDA:
Don't blame us for Avastin change
Fierce
Pharma 6/19/08
Roche
Enters Deal for Cancer Drug
Seeking
Alpha 6/19/08
Sanofi
Makes Offer for Generic Firm Zentiva
Seeking
Alpha 6/19/08
Pfizer's
Lipitor deal not a long-term solution
M
Live 6/19/08
Schering-Plough
CEO Fred Hassan Reflects on Adversity
WSJ
Online 6/19/08
Novartis yanks pre-pandemic vaccine application
Fierce
Bioresearcher 6/19/08
Discovery
Labs' Surfaxin response to FDA delayed
Yahoo/AP
6/19/08
Elan, Wyeth: Response to Skeptics on Alzheimer's Data
Seeking
Alpha 6/19/08
J&J
unit buys diagnostics company; Gleevec linked to muscle damage
Fierce
Pharma 6/19/08
Mannkind:
Overlooked Biotech With Excellent Prospects (Part V)
Seeking
Alpha 6/19/08
Forest
Embarrassed Investors Who May Still Be Right
Bloomberg
6/19/08
Sepracor
shares rise on late-stage seizure drug data, UBS analyst upgrade
Yahoo/AP
6/19/08
Merck Applies to Extend Use of Erbitux for First-Line Head and
Neck Cancer in Europe
PharmaLive
6/19/08
Sanofi,
Merck's Gardasil Picked For Denmark Immunization Plan
Easy
Bourse, France 6/19/08
Alcon
Raises Guidance as Stock Soars
Seeking
Alpha 6/19/08
Wuxi
Pharma: Too Much of a Good Thing
Seeking
Alpha 6/19/08
Alnylam
signs drug deal with Japanese pharma
Yahoo/AP
6/19/08
|
|
Tweaked
Glaxo drugs mired in approval delays
Fierce
Pharma 6/18/08
Slow
sales open drugmakers to growth abroad
Newark
Star Ledger, NJ 6/18/08
Biotech
still a sales star
Newark
Star Ledger, NJ 6/18/08
Pfizer,
Ranbaxy deal would delay generic Lipitor
Forbes/Reuters
6/18/08
Pfizer: Low Expectations Make Great Investments
Seeking
Alpha 6/18/08
Countdown
to Expiry: Lipitor Goes Generic on 11/30/11
WSJ
Online 6/18/08
Hope
Mixes With Doubt For Alzheimer's
Forbes
6/18/08
Sanofi plans €1.7bn counterbid for Zentiva
FT.com
6/18/08
Pharma to Sit on DTC Ads
PharmExec
6/18/08
Alzheimer's
Drug Shows Progress
Yahoo/Businessweek
6/18/08
Elan climbs to 6-year high on study results
Yahoo/AP
6/18/08
Roche Buys Cancer Drug From ThromboGenics, BioInvent
Bloomberg
6/18/08
TEVA:
Breakthrough in Treatment of Parkinson's Disease
Seeking
Alpha 6/18/08
What
Tiger Woods and Israeli Pharma Teva have in common
iStockAnalyst
6/18/08
Ala.
attorney: 2 drug companies cheated Medicaid
Forbes/AP
6/18/08
Allergan wins approval for ocular inflammatory drug
Pharmaceutical
Business Review 6/18/08
[video]Genzyme CEO on Growth
CNBC
6/18/08
Fontus
acquires thyroid drug from Roche
Pharmaceutical
Business Review 6/18/08
SuperGen's
cancer drug found effective against tumor growth
Pharmaceutical
Business Review 6/18/08
UK
drug pricing deal to cut company profits - report
Hemscott,
UK 6/18/08
J&J,
American Red Cross resolve emblem dispute
Yahoo/AP
6/18/08
Body Smoothing May Not Be Grooving For Medicis
Forbes
6/18/08
Pharming's angioedema drug meets study end point
Pharmaceutical
Business Review 6/18/08
Merck
Serono and Bionomics Announce Multiple Sclerosis Development and
Licensing Agreement
PR
Newswire , UK 6/18/08
Seattle
Genetics Achieves Milestone Under Antibody-Drug Conjugate Collaboration
Triggered by Genentech's IND Filing
Yahoo
6/18/08
Ark gets positive results from pre-clinical angina drug tests
Interactive
Investor 6/18/08
Celsis
Shares Rise As Pharma Cos Seek Quicker Tests
Easy
Bourse, France 6/18/08
|
|
Elan
Reports Mixed Alzheimer Results
TheStreet.com
6/17/08
Why
E-Prescribing Hasn’t Caught On
WSJ
Online 6/17/08
Novartis'
Tekturna Shows Positive Results in Study
Bloomberg
6/17/08
Antipsychotics
and the Elderly
NY
Times 6/17/08
Allergan
wins FDA approval for retinal injection
Yahoo/AP
6/17/08
Glaxo's Generic-Drug Defense Tactic Questioned, WSJ Says
Bloomberg
6/17/08
Glaxo
invests $15 million in California company
Trading
Markets 6/17/08
More Cancer Issues for Johnson & Johnson
Motley
Fool 6/17/08
Health
Winners & Losers: Teva
TheStreet.com
6/17/08
Bright
Prospects for J&J Psoriasis Drug
WSJ
Online 6/17/08
Boehringer
to buy Actimis for $515 million if drug works
Reuters
6/17/08
Mylan
receives tentative FDA approval for generic version of Sanofi
Aventis hypertension drug
Yahoo/AP
6/17/08
Takeda
Asks Europe Regulators to Review Insomnia Drug Rejection
Bloomberg
6/17/08
Bioterrorism:
Anthrax and Biotech Companies
SeekingAlpha
6/17/08
Alkermes
shares rise on outlook for 2009 profit
Forbes/AP
6/17/08
Novo
Nordisk says diabetes drug boosts weight loss
Forbes
6/17/08
Letter Challenges Biovail CEO to a Debate
Trading
Markets 6/17/08
Mannkind: Overlooked Biotech With Excellent Prospects (Part IV)
SeekingAlpha
6/17/08
A
Quiet Medicines Co. Raises Questions
TheStreet.com
6/17/08
SuperGen's
leukemia drug found to induce tumor regression in xenograft models
Pharmaceutical
Business Review 6/17/08
Medicis buying LipoSonix and its fat-reducing technology for $150
million in cash
Yahoo/AP
6/17/08
Lupin
Asks Court for Ramipril Go-Ahead
FDA
News 6/17/08
SkyePharma
Says Asthma Drug Flutiform Met Main Goal of Study
Bloomberg
6/17/08
Cypress Bioscience up as analysts say FDA OK of Lilly's Cymbalta
bodes well for co.'s drug
Yahoo/AP
6/17/08
Monogram
Bio Must Manage Growth
Yahoo/Zacks.com
6/17/08
|
|
FDA
approves Eli Lilly's Cymbalta for Fibromyalgia
Marketwatch
6/16/08
Glaxo,
SkyePharma gain on Requip XL drug approval
Guardian,
UK 6/16/08
Lilly,
diabetes market pin hopes on weekly Byetta
Indianapolis
Star, IN 6/16/08
GSK tops rankings on drug access for poor
Fierce
Pharma 6/16/08
Glaxo,
Novo Nordisk, Merck Lead in Getting Drugs to the Poor
Bloomberg
6/16/08
Amgen's Enbrel in kids "concerning": FDA staff
Reuters
6/16/08
Biotech
stocks open lower as market falls on regional manufacturing decline,
oil prices
Yahoo/AP
6/16/08
Teva
says data demonstrates Azilect slows progression of Parkinson's
disease
Yahoo/AP
6/16/08
Drug
cuts risk of prostate cancer by 30%, study shows
IHT
6/16/08
Novartis
withdraws influenza vaccine application
Reuters,
UK 6/16/08
Sanofi
Pasteur to Donate 60 Million Doses of H5N1 Vaccine to WHO Over
3 Years for its Influenza Vaccine Global Stockpile
Yahoo
6/16/08
Novartis,
German health insurer AOK in deal over Lucentis as wet AMD treatment
Forbes
6/16/08
Teva gets FDA nod for generic high blood pressure drug
Globes,
Israel 6/16/08
Who
is this guy? And does Eli Lilly need to be afraid of him?
Indianapolis
Star, IN 6/16/08
Acadia
schizophrenia drug no better than placebo in mid-stage trial;
shares plummet
Yahoo/AP
6/16/08
Analyst
Comments: Alexza Pharma, Abbott Lab, Metabasis, Quicksilver, ASM
International
iStockAnalyst
6/16/08
Exelixis
gets FDA nod for thyroid cancer drug trial
Yahoo/AP
6/16/08
Bentley spin-off of CPEX is step toward Teva acquisition
Globes,
Israel 6/16/08
Bionovo
Discovers New Estrogen Regulatory Elements for Breast Cancer and
Osteoporosis Drugs
Trading
Markets 6/16/08
Pain
Therapeutics Encouraged by Results of Melanoma Clinical Study
Yahoo
6/16/08
KV
Pharmaceutical Company Reports Fiscal 2008 Results
MSN
Money 6/16/08
ChemGenex
Says Drug Fights Cancer in Drug-Resistant Patients
Bloomberg
6/16/08
|
|
More
cost cuts in pipeline for European pharma
Reuters
6/15/08
China
Biotech Week in Review: Deals and Drugs
Seeking
Alpha 6/15/08
Elan,
Wyeth Take an Inside-Out Approach to Alzheimer's Vaccine
Seeking
Alpha 6/15/08
Glaxo:
Revolade Shows Long-Term Sustained Platelet Levels
Smart
Money 6/15/08
Will
NeuroMetrix Inc. Win Back the Hearts of Investors?
Seeking
Alpha 6/15/08
Glaxo Gears Up a Blockbuster
Motley
Fool 6/14/08
Big
Pharma Stocks Aren't Playing Defense
Investors
Business Daily 6/14/08
Wyeth's
combination therapy found effective against rheumatoid arthritis
Pharmaceutical Business Review 6/14/08
Pfizer
Makes A Play To Keep Lipitor
Forbes
6/14/08
US senator seeks FDA probe of Glaxo's Paxil data
Reuters
6/14/08
Lilly,
diabetes market pin hopes on weekly Byetta
6/14/08
Goldman
Sachs: ImClone's Erbitux poised for growth
Yahoo
6/14/08
Health
Winners & Losers: Maxygen
The
Street 6/14/08
Glivec
misses target in clinical study
Forbes
6/14/08
Lilly
Patches Its Pipeline
Motley
Fool 6/14/08
Kendle
shares rise on continued growth outlook
Forbes
6/14/08
Biotech Watch: Elan's Alzheimer's Drug Data
The
Street 6/14/08
Novo
Nordisk Bleeds a Little
Motley
Fool 6/14/08
Preliminary
Results from International Study Report That REVLIMID(R) Provides
Responses for Patients with Relapsed/Refractory Aggressive Non-Hodgkin's
Lymphoma
Yahoo
6/14/08
U.S.
FDA Approves Requip(R) XL(TM), the First and Only Oral Once-Daily
Non-Ergot Dopamine Agonist for Parkinson's Disease
istockanalyst
6/14/08
Teva
wins tentative approval for hypertension drug
Trading
Markets 6/14/08
Rigel
initiates two Phase IIb rheumatoid arthritis trials
Pharmaceutical
Business Review 6/14/08
Some
Insight Into Incyte's Data
The
Motley Fool 6/14/08
Lorus
Therapeutics Announces Rights Offering to Shareholders
Yahoo
6/14/08
Exelixis
Presents Clinical Data Supporting the Safety and Initial Clinical
Activity of XL228 in Chronic and Acute Leukemia
Yahoo
6/14/08
SuperGen's
PIM Kinase Inhibitor, SGI-1776, Causes Tumor Regression in AML
Xenograft Models
PR NewsWire 6/14/08
VIDAZA(R)
Continues to Show Significant Overall Survival Benefit When Compared
with Conventional Care Regimens Across the EU
Trading
Markets 6/14/08
First New Oral Anticoagulant In More Than 40 Years Approved In
Canada
Medical
News Today 6/14/08
Opko
Acquires Rights to Viral Conjunctivitis Drug
RedOrbit
6/14/08
Abraxis
to Appeal Jury Ruling on Elan Patent Infringement Claim
Yahoo
6/14/08
FDA backs new tests to monitor drug safety
San
Francisco Gate, CA 6/14/08
A
Brave New World for Pharmaceuticals
PharmaTech
Talk 6/14/08
|
|
Pfizer
may make counter bid for Ranbaxy
Reuters
6/13/08
Merck
Looking to Cut Costs
Yahoo/Zacks.com
6/13/08
Eli Lilly buys osteoporosis drug patch for $35M
Boston
Globe, MA 6/13/08
FDA
may require cancer-risk labeling on J&J drug
Yahoo/AP
6/13/08
Senator seeks FDA probe of Glaxo's Paxil data
Reuters,
UK 6/13/08
Bagging
Applied Biosystems On The Cheap
Forbes
6/13/08
[video]Beantown
Biotech Roundtable
CNBC
6/13/08
Pfizer,
Avant, Wyeth And Elan: Your Emails
CNBC
6/13/08
Novartis
cancer drug no better in higher dose
CNN
Money 6/13/08
Eli
Lilly says study shows antidepressant Cymbalta reduces pain from
knee osteoarthritis
Yahoo/AP
6/13/08
Roche's
Actemra helps in hard-to-treat arthritis
Guardian,
UK 6/13/08
ImClone/Merck/Bristol-Myers:
Erbitux set for breakthrough in Japan
Pharmaceutical
Business Review 6/13/08
AstraZeneca
Reps Strike Gold in China’s Provinces
WSJ
Online 6/13/08
Pfizer
Gets Two Opinions from the WSJ
Seeking
Alpha 6/13/08
GlaxoSmithKline's
Cutbacks Should Come as No Surprise
Seeking
Alpha 6/13/08
Biotech
Fundamentals Still Look Strong
Seeking
Alpha 6/13/08
AstraZeneca
announces outsourcing in two departments
Delaware
Online 6/13/08
Valeant
says hepatitis C drug causes less anemia
Hemscott,
UK 6/13/08
Long-term
data demonstrates efficacy of Abbott arthritis drug Humira for
up to 7 years
Yahoo/AP
6/13/08
Mannkind:
Overlooked Biotech With Excellent Prospects (Part III)
Seeking
Alpha 6/13/08
Gilead
Announces Interim 12-Month Phase III Study Results for Aztreonam
Lysine for Inhalation in Patients With Cystic Fibrosis
Street
Insider 6/13/08
NicOx
announces blood pressure analysis from 301 phase 3 study for naproxcinod
at EULAR
FOX
Business 6/13/08
The
FDA and the Tumor
NY
Sun 6/13/08
EntreMed
granted new patent for 2-methoxyestradiol analogs
Pharmaceutical
Business Review 6/13/08
Invitrogen
to buy Applera unit for $6.7B
M
Live 6/13/08
|
|
What
Happened to the Pharmaceutical Sector?
iStockAnalyst
6/12/08
Wyeth
and Elan Face Big Test on Alzheimer's Drug
SeekingAlpha
6/12/08
He
Said, Biogen Said
Motley
Fool 6/12/08
Inside
India's Shocker Pharma Deal
Businessweek
6/12/08
Dueling
Fools: Pfizer
Motley
Fool 6/12/08
Dueling
Fools: Pfizer Bull
Motley
Fool 6/12/08
Dueling
Fools: Pfizer Bear
Motley
Fool 6/12/08
Bristol-Myers
says study shows Orencia blocks spread of rheumatoid arthritis
over 3 years
Yahoo/AP
6/12/08
Genentech,
MedImmune settle patent dispute
MSN
Money 6/12/08
Analysis:
sugaring the generics pill
Times
Online, UK 6/12/08
Industry
Insider: A click closer to Rx information
Star
Ledger, NJ 6/12/08
Drugmakers'
U.S. Sales Slump Boost Novartis, Schering
Bloomberg
6/12/08
Big
Pharma’s Academic Courtship Continues
With Pfizer-UCSF, Glaxo-IDI Research Pacts
Biotech
Transfer 6/12/08
Is
Pfizer's 7% Dividend Safe?
SeekingAlpha
6/12/08
Pfizer
stock down again as Chantix takes its toll
The
Day, CT 6/12/08
Amylin's
Down and Up on Diabetes
Motley
Fool 6/12/08
Stay
Confident About Biotech
Zacks.com
6/12/08
Mylan
Takes Generic Aim at Teva
Motley
Fool 6/12/08
Jazz
Pharmaceuticals to cut 33 people, delay two drugs
Bizjournals
6/12/08
Genentech
Buys Stake in Symphogen to Gain Antibody Technology
Bloomberg
6/12/08
A Look at the Major Drugs Industry
iStockAnalyst
6/12/08
In
GLP-1 Wars, Novo & Others Knock at Amylin’s Door; Find
Amylin Moved to Pricier Digs
SeekingAlpha
6/12/08
Not
Much Downside for Eli Lilly
Yahoo/Zacks.com
6/12/08
Dendreon's
Provenge: Government Agencies Play Hide and Seek With Facts
SeekingAlpha
6/12/08
Slow
sales for Glaxo diet drug
The
Day, CT 6/12/08
Lupin
Launches Ramipril Capsules
RedOrbit
6/12/08
Merck
KGaA to sell Bristol-Myers Squibb drugs in Latin America
Hays
Pharma, UK 6/12/08
|
|
Daiichi
Sankyo to Buy Ranbaxy for as Much as $4.6 Bln
Bloomberg
6/11/08
Glaxo
axes 350 jobs in overhaul of drug research
Boston
Globe, MA 6/11/08
Big
Pharma's R&D Booster Shot
Businessweek
6/11/08
ADA
Hearts Amylin
Forbes
6/11/08
Roche
says its arthritis drug more effective
Guardian,
UK 6/11/08
Sanofi
Acomplishes Little With Acomplia
Forbes
6/11/08
Drug
shares at multiyear lows; no relief in sight
Reuters
6/11/08
Is
Lilly and Amylin's Byetta Better?
Seeking
Alpha 6/11/08
Studies
Show J&J, Schering-Plough Arthritis Drug Effective
CNN
Money 6/11/08
Drug
Makers Enter a New Era of Sharing
NJ
Biz 6/11/08
Bristol-Myers
Squibb and Pfizer Initiate New Study in the Apixaban Phase 3 Clinical
Trial Program
TheFinancial
6/11/08
Bristol
shares hit 6-year low on diabetes data
Forbes
6/11/08
Pfizer May Buy Tianjin Tianyao Pharma
Seeking
Alpha 6/11/08
Genentech:
collaboration prompts speculation over infectious disease interests
Pharmaceutical
Business Review 6/11/08
Biogen
Got $82-a-Share Offer From Icahn, Company Says
Bloomberg
6/11/08
Mylan:
Appeals court says generic Prilosec doesn't violate AstraZeneca
patents
Forbes
6/11/08
Barr challenges patent of TAP's of Prevacid tablets after infringement
suit
Forbes
6/11/08
Mannkind: Overlooked Biotech With Excellent Prospects (Part II)
Seeking
Alpha 6/11/08
UCB and Otsuka to co-promote Keppra and Cimzia in Japan
Pharmaceutical
Business Review 6/11/08
Amarillo
Biosciences Files Patent to Treat Obesity With Oral Interferon
Yahoo
6/11/08
ALK-Abello's allergy drug found to reduce asthma symptoms in children
Pharmaceutical
Business Review 6/11/08
|
|
Diabetes
drug competition in focus at ADA meeting
CNN
Money 6/10/08
Takeda's
Actos prevents diabetes, study finds
Reuters
6/10/08
[video]Game-Changers
in Cancer Therapy
Yahoo/Morningstar
6/10/08
Pfizer
Completes Acquisition of Encysive Pharma
RTT
News 6/10/08
Novo
pushes for early use of insulin
Star
Ledger, NJ 6/10/08
Sanofi-Aventis:
Acomplia trial sees improved glucose control
Marketwatch
6/10/08
Amylin,
Lilly, Alkermes report progress with diabetes drug
Marketwatch
6/10/08
Novo
Nordisk: Over 70% of diabetes patients reach target in study
Hays
Pharma, UK 6/10/08
Sanofi-Aventis
says Lantus injection Helps Type 2 Diabetes patients reach the
ADA's Recommended Target for Blood Sugar Control
RTT
News 6/10/08
Vertex
shares rise on hepatitis C drug data in patients who failed prior
regimen
CNN
Money 6/10/08
Abbott
Labs: Dividend Analysis
Seeking
Alpha 6/10/08
Mylan
receives FDA approval to market Zaleplon, insomnia treatment is
generic of King's Sonata
Yahoo/AP
6/10/08
Mylan
to distribute generic version of Teva's Copaxone
Marketwatch
6/10/08
Pain
Therapeutics and King Pharmaceuticals Announce Submission of New
Drug Application for Remoxy
Yahoo
6/10/08
Isis Highlights Robust Drug Portfolio for Diabetes and Obesity
at ADA Conference
Yahoo
6/10/08
Treading on a Johnson & Johnson Product
Motley
Fool 6/10/08
CytRx
shares fall on study delay for Lou Gehrig's drug candidate, acquisition
news
Yahoo/AP
6/10/08
WuXi
PharmaTech (NYSE: WX) Expands Collaboration With AstraZeneca
Yahoo
6/10/08
Targacept and AstraZeneca Initiate Clinical Trial of AZD3480 in
Adult ADHD
Yahoo
6/10/08
|
|
AstraZeneca
diabetes drug proved effective, safe in late-stage trials
CNBC
6/9/08
Marcial:
The Formula for a Pfizer Recovery
Businessweek
6/9/08
Allergan
buys QLT acne gel Aczone for $150 million, expects to launch product
in 4th quarter
Yahoo/AP
6/9/08
J&J
signs potential deal with Astex
Interactive
Investor 6/9/08
Analyst says Regeneron oversold on drug failure
Forbes
6/9/08
Pfizer Research Chief’s Personal Take on Chantix
WSJ
Online 6/9/08
Harvard
Doctors Failed to Disclose Fees, Senator Says
Bloomberg
6/9/08
Brazil's
Biotech Firms: From Imitators To Innovators In Health-Related
Products
Medical
News Today, UK 6/9/08
Merck reports added benefits to its Januvia oral diabetes drug
Hemscott,
UK 6/9/08
Novo
Nordisk's 24-Hour Levemir Matches Glargine Insulin in Test
Bloomberg
6/9/08
FDA Triples Count of Heparin-Related Deaths
WSJ
Online 6/9/08
Takeda
says alogliptin oral diabetes drug effective
Forbes
6/9/08
Denmark's Novo boosted by strong liraglitude and Levemir data
PharmaTimes,
UK 6/9/08
Discovery
Labs: Panic at the DSCO
Seeking
Alpha 6/9/08
Big
pharma responds to EU anti-counterfeiting
Outsourcing
Pharma 6/9/08
Mannkind:
Overlooked Biotech With Excellent Prospects (Part I)
Seeking
Alpha 6/9/08
Innate Pharma Wants New Novo Nordisk Deal First, Brailly Says
Bloomberg
6/9/08
Halozyme Therapeutics Announces Phase I Clinical Trial Results
Demonstrating that the Combination of Recombinant Human Hyaluronidase
(rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster,
More Physiologic Insulin Kinetics and Better Predictability
Yahoo
6/9/08
POZEN Demonstrates Bioequivalence to Enteric Coated Aspirin for
PA32540
Yahoo
6/9/08
Sucampo Pharma Europe Submits Marketing Authorization Application
in Switzerland
Yahoo
6/9/08
|
|
Elan
offered to help Biogen bidder
Irish
Independent, Ireland 6/8/08
Abbott's
Phase III Sub-Group Analysis Shows Investigational TriLipix(TM)
in Combination with CRESTOR(R) Improves Key Lipids in Patients
with Mixed Dyslipidemia and Type 2 Diabetes
iStockAnalyst
6/8/08
Monotherapy
BYETTA(R) (exenatide) Injection Study Results Presented at ADA
2008 Showed Adults with Type 2 Diabetes Experienced Improved Glycemic
Control and Weight Loss
PR
NewsWire 6/8/08
New
Data Released at Major Diabetes Meeting on Initial Combination
Therapy with JANUVIA(TM) (sitagliptin), Merck's Diabetes Medicine,
and Metformin through Two Years of Treatment
Yahoo
6/8/08
Phase 3 Results for Alogliptin Demonstrated Significant Blood
Sugar Reductions in Monotherapy and Four Add-On Therapy Studies
Genetic
Engineering News 6/8/08
XOMA
052 Demonstrates Anti-Inflammatory Effects in Diabetes Animal
Studies; Data Presented At ADA
Trading
Markets 6/8/08
Synvista Therapeutics Reports Results of Three Phase 2 Clinical
Trials of SYI-2074 in Diabetic Patients with Cardiovascular Disease
Fox
Business 6/8/08
ONGLYZA(TM)
(saxagliptin) Demonstrated Significant Reductions in Key Measures
of Glucose Control in Treatment Naive People with Type 2 Diabetes
Yahoo
6/8/08
Roxane Laboratories, Inc. Announces the Launch of Zaleplon Capsules
CIV
Fox Business 6/8/08
Government
Control Of Drug Prices Will Stifle Research And Development
Tri
Cities TN 6/8/08
Sorry,
Sanofi: More Bad News
Motley
Fool 6/7/08
Nothing
Can Stop Novartis!
Motley
Fool 6/7/08
Analyst
says Regeneron oversold on drug failure
Yahoo
6/7/08
Fixing
Pharma
Forbes
6/7/08
Taro
asset-stripping plan to thwart Sun
Sify,
India 6/7/08
Strong
Vertex Pharma Pipeline
Yahoo/Zacks
6/7/08
Sangamo
shares drop on plans to expand study
Yahoo/AP
6/7/08
Catalyst Pharmaceutical files shelf registration
Bizjournals
6/7/08
Suicidal
Behavior Warning Coming Soon for Epilepsy Drugs
Wall
Street Journal 6/7/08
FDA
adds cancer warnings to J&J foot ulcer cream
Yahoo
6/7/08
Callisto
initiates Phase I irritable bowel syndrome trial
Pharmaceutical
Business Review 6/7/08
Akesis
completes dosing of Phase IIa Type 2 diabetes trial
Pharmaceutical
Business Review 6/7/08
PharmaGap
establishes clinical development group to take drug to clinical
trials
Fox
Business 6/7/08
Synvista
Therapeutics Reports Results of Three Phase 2 Clinical Trials
of SYI-2074 in Diabetic Patients with Cardiovascular Disease
Earth
Times 6/7/08
FDA
clears reintroduction of ProHeart 6 to the veterinary channel
DVM
News 6/7/08
|
|
FDA
to probe link between childhood cancer, Abbott's Humira
Trading
Markets 6/5/08
ASCO's
Take-Home and the Oncology Market
PharmExec
6/5/08
Analysts
have high hopes for Abbott Laboratories
Medill
Reports 6/5/08
Pfizer
falls as analyst downgrades on lower pipeline estimates; Schering-Plough
upgraded
Yahoo/AP
6/5/08
Pfizer's
Full-Court Press to Save Chantix
PharmExec
6/5/08
Merck
Wins Suit on Vioxx Monitoring
WSJ
Online 6/5/08
Congress
to Doctors: Start e-Prescribing or Take a Medicare Pay Cut
WSJ
Online 6/5/08
Lilly nears regulator decision on key cardio drug
Chicago
Tribune 6/5/08
Analyst
Notes: Lilly Gets A Lift, Pfizer Goes Pfft
Seeking
Alpha 6/5/08
Novartis
Ups Fight Vs. Drug-Resistant Infections
Forbes
6/5/08
Takeda new diabetes drug seen good but not great
Guardian,
UK 6/5/08
Sanofi's
U.S. Ambitions Dragged By Drug
Forbes
6/5/08
AstraZeneca's Crestor winning U.S. market share
Reuters
6/5/08
Inhaler
Devices Are Still a Major Hurdle in Asthma and COPD Treatment
Red
Orbit 6/5/08
Erbitux's
Deceptively Disappointing Results
Motley
Fool 6/5/08
Indevus
Pharmaceuticals: Nebido Has Lost Its Libido
Seeking
Alpha 6/5/08
BioMarin
to give research and development update; analyst seeks PEG-PAL
and Kuvan details
Yahoo/AP
6/5/08
Hungry
big pharma circles Swiss biotech Actelion
Reuters
6/5/08
DxS,
Roche Expand KRAS Dx Distribution; ASCO Studies Support mCRC KRAS
Testing
Pharmacogenomics
Reporter 6/5/08
Martek
offers 3Q outlook in range of Street
Yahoo/AP
6/5/08
ZymoGenetics, Merck KGaA start additional phase II/III study of
Atacicept
Forbes
6/5/08
Compelling Impella: Abiomed May Double Its Revenues
Seeking
Alpha 6/5/08
Industry
Insider: Gardasil's girl talk hits big screen
Newark
Star Ledger, NJ 6/5/08
Lexicon's
cancer drug granted fast track status from FDA
Pharmaceutical
Business Review 6/5/08
Cephalon
files patent infringement lawsuit against Watson Pharmaceuticals
Pharmaceutical
Business Review 6/5/08
Ipsen to Acquire Tercica
PharmaLive
6/5/08
|
|
Astra
seeks US approval for Symbicort
Boston
Globe, MA 6/4/08
Novartis buys antibiotics maker Protez
Businessweek
6/4/08
Diabetes
Drugs Could Sweeten Shares
Barrons
6/4/08
Drug
Titans Face Off on 2 Cancer Treatments
Red
Orbit 6/4/08
Pharmacopeia gets $500,000 payment from GlaxoSmithKline for identifying
respiratory compound
Yahoo/AP
6/4/08
FDA's
Brain Drain Clogs Process
Harford
Courant, CT 6/4/08
Dividend
may test Pfizer
TheDay,
CT 6/4/08
Allergan
Announces Intent to File New Drug Application for Bimatoprost
as Novel Treatment to Stimulate Natural Eyelash Growth
iStockAnalyst
6/4/08
Drug
avoids radiation for early testicular cancer
Reuters
6/4/08
Study
Questions Drugmakers' Hunt for `Good' Cholesterol Booster
Bloomberg
6/4/08
Antibody drug cost-effective for allergic asthma
Reuters,
UK 6/4/08
Bayer
HealthCare acquires Sagmel's OTC business
Pharmaceutical
Business Review 6/4/08
Indevus
Plunges as U.S. Request Delays Nebido for Two Years
Bloomberg
6/4/08
Daiichi Sankyo launches Gracevit tablets
Pharmaceutical
Business Review 6/4/08
Sanofi-aventis Report Encouraging Trovax Phase II Trial Results
in Metastatic Renal Cancer
TheFinancial
6/4/08
Vertex
sells HIV royalty stream for $160 million
Boston
Globe, MA 6/4/08
Novo
Nordisk completes Phase I trial of hemophilia drug
Pharmaceutical
Business Review 6/4/08
Boehringer
Ingelheim, Gilead Agree to AIDS Drug Price Freeze
PR
Inside, Austria 6/4/08
Addex Pharmaceuticals Starts Phase I ADX10059 Interaction Study
Street
Insider 6/4/08
CuraGen
reports promising results from Phase I/II melanoma study
Pharmaceutical
Business Review 6/4/08
Mylan
acquires Merck's CEE generics businesses
Pharmaceutical
Business Review 6/4/08
|
|
Pfizer
to start seven Phase III studies of cancer drugs in 2008
Forbes
6/3/08
Pfizer Hits Lowest Level Since 1997
SeekingAlpha
6/3/08
Sanofi's
Drug Linked to Deaths, Including Suicide, U.K. Says
Bloomberg
6/3/08
Breast cancer drugs in the spotlight
Businessweek
6/3/08
Bristol-Myers,
ImClone, Genentech Release Promising Data at ASCO
SeekingAlpha
6/3/08
[video]Cancer
Conference Highlights
CNBC
6/3/08
Lean
Times Could Strain Pfizer’s Fat Dividend
WSJ
Online 6/3/08
ASCO Demonstrates Progress vs. Cancer
Zacks.com
6/3/08
Amgen
Presents New Data At ASCO On Four Investigational Molecules From
Oncology Pipeline
Medical
News Today, UK 6/3/08
Wyeth
initiates Phase IIIb renal cell carcinoma trial
Pharmaceutical
Business Review 6/3/08
Mix
of Good, Bad News for ImClone's Erbitux at ASCO
Bioworld
Online 6/3/08
French
drug giant Sanofi-Aventis obstructed inquiry, say EU officials
Times
Online, UK 6/3/08
AstraZeneca
files sNDA for ulcer drug
Pharmaceutical
Business Review 6/3/08
In
Breast Cancer Patients With Diabetes Metformin Increases Pathologic
Complete Response Rates
Medical
News Today, UK 6/3/08
Biovail
Founder Melnyk Seeks Change at `Broken' Firm
Bloomberg
6/3/08
Vertex
Pharmaceuticals Sells HIV Product Royalty Stream for $160 Million
Yahoo
6/3/08
Amylin
Pharmaceuticals to Present Promising Data From Diabetes and Obesity
Programs at ADA 2008
CNN
Money 6/3/08
Sepracor
Completes Acquisition of Oryx Pharmaceuticals and Expands Operations
in Canada
Genetic
Engineering News 6/3/08
PDL
BioPharma: Take the LEAPS
SeekingAlpha
6/3/08
Ipsogen
launches new cancer diagnostic test
Pharmaceutical
Business Review 6/3/08
Sanofi-aventis
Report Encouraging Trovax Phase II Trial Results in Metastatic
Renal Cancer
The
Financial 6/3/08
Avant
Climbs on Updated Study Data
TheStreet.com
6/3/08
Antisoma
touts ASA404 survival benefit at ASCO
PharmaTimes,
UK 6/3/08
Watson
Pharmaceuticals gets FDA OK for application for hypokalemia capsules
Hemscott,
UK 6/3/08
Roche
NimbleGen and BioDiscovery Form Strategic Alliance to Enhance
CGH Microarrays, Software and Services
PharmaLive
6/3/08
Paladin
Labs Inc.: New Improved Dosing Approved for Pennsaid(R)
Genetic
Engineering News 6/3/08
|
|
Abbott
reports positive results for TriLipix cholesterol drug
Forbes
6/2/08
Minnesota Doctors: No Free Frozen Yogurt for You!
WSJ
Online 6/2/08
Roche
Rises Most in Three Months on Avastin Data
Bloomberg
6/2/08
Are
Two Targeted Cancer Drugs Better Than One?
WSJ
Online 6/2/08
ImClone and Bristol-Myers to 'FLEX' Muscles at ASCO
Seeking
Alpha 6/2/08
Emerging
Markets Play Bigger Role For Pharma
Yahoo/Investors
Business Daily 6/2/08
Celebrex shows promise in lung cancer prevention
Yahoo/Reuters
6/2/08
Bone drug Zometa helps women with early breast cancer
USA
Today 6/2/08
ASCO
AT A GLANCE: Genetic Research A Focus Of Cancer Meeting
Easy
Bourse, France 6/2/08
Study
is seen as boost for ImClone
Boston
Globe. MA 6/2/08
New
Hope for a Failed Cancer Drug
Businessweek
6/2/08
No
Love for Antibiotics From the FDA
Motley
Fool 6/2/08
Merck's
Movie "Script" For Advertising Its Cervical Cancer Drug
CNBC
6/2/08
AIDS Vaccine Linked to Failed Merck Product Nears Human Testing
Bloomberg
6/2/08
Novartis says early data reveal RAD001's potential for breast
cancer therapies; To initiate new trial in early 2009
RTT
News 6/2/08
Schering-Plough's
Sugammadex Provides Fast Reversal of Effects of Muscle Relaxants
Used in General Anesthesia
Yahoo
6/2/08
EU targets Sanofi over possible probe obstruction
Guardian,
UK 6/2/08
Watson
gets approval to sell generic of AstraZeneca heartburn drug Prilosec
Yahoo/AP
6/2/08
Celgene Withdraws European Union (EU) Marketing Authorization
Application for Lenalidomide in Deletion-5Q Myelodysplastic Syndromes
Yahoo
6/2/08
Bayer/J&J's rivaroxaban shows superiority over Lovenox
PharmaTimes,
UK 6/2/08
Merck
KGaA Shares Fall Most Since January on Erbitux Data
Bloomberg
6/2/08
Wyeth Initiates INTORACT -- A New Clinical Trial to Examine TORISEL
Plus Avastin for First-Line Treatment of Advanced Kidney Cancer
Yahoo
6/2/08
EU agency supports new use of Merck's Gardasil
Reuters,
UK 6/2/08
As
Bad News Mounts, Chantix Prescriptions Crumble
WSJ
Online 6/2/08
Mylan
acquires eastern European Merck KGaA units
Forbes
6/2/08
GPC Biotech Says Satraplatin Didn't Boost Survival in Study
Bloomberg
6/2/08
Solvay reports positive cholesterol drug trials
Forbes
6/2/08
Acorda Rises After Fampridine Helps MS Patients Walk Faster
Bloomberg
6/2/08
Novo Nordisk and Neose Announce Completion of Initial Phase 1
Clinical Trial of NN7128 (Long-Acting Factor VIIa)
Yahoo
6/2/08
|
|
Merck
Wins Vioxx Appeals
Forbes
5/30/08
Bayer:
Study shows Rivaroxaban superiority to Lovenox
Marketwatch
5/30/08
Health
Winners & Losers: Kosan
TheStreet.com
5/30/08
Do
Pfizer & Bristol-Myers Squibb "Ad" Up?
CNBC
5/30/08
Icahn Girds for Biogen Battle
Motley
Fool 5/30/08
Lung
cancer data meeting's main attractions
Star
Ledger, NJ 5/30/08
Roche's
Herceptin Helps Slow Breast Cancer in Study
Bloomberg
5/30/08
J&J
clot-drug study succeeds, lifting U.S. prospects
Reuters
5/30/08
AstraZeneca Submits sNDA for NEXIUM(R) I.V. for Peptic Ulcer Bleed
Indication
PR
Newswire 5/30/08
Big Pharma Pipelines Failing to Meet Expectations
Seeking
Alpha 5/30/08
Gilead
Buys Hypertension Drug Candidate
TheStreet.com
5/30/08
Lilly
Submits Cymbalta(R) Supplemental New Drug Application For Chronic
Pain To U.S. Food And Drug Administration
Medical
News Today 5/30/08
Fixing Pharma
Forbes
5/30/08
FDA requests more info on Wyeth's pneumonia drug
Yahoo/AP
5/30/08
Sector Wrap: Pharma stocks remain bogged down
Forbes
5/30/08
Pfizer’s Celebrex: Mass Tort Madness
Seeking
Alpha 5/30/08
Bristol-Myers
reaffirms 2008 guidance
Yahoo/AP
5/30/08
As Promised, Alnylam Forms Another Big
Pharma Alliance, This Time With Takeda
RNAi
News 5/30/08
Pharmacopeia
to cut 15 percent of work force
Yahoo/AP
5/30/08
PDL BioPharma's acting CEO resigns over differences about company
strategy
Bizjournals.com
5/30/08
Barr
Tries to Right Itself After a Stumble
Businessweek
5/30/08
ViroPharma
completes enrollment in Phase III study of antiviral drug
Pharmaceutical
Business Review 5/30/08
|
|
Glaxo,
Ligand drug gets negative FDA assessment
Boston
Globe, MA 5/29/08
Top
Selling Drugs for 2007
Pharmababble
5/29/08
Prescriptions
for Vytorin Keep Falling
WSJ
Online 5/29/08
Biotech Sector Continues to Outperform
SeekingAlpha
5/29/08
Merck
KGaA's Erbitux Drug May Get Edge on Avastin
Bloomberg
5/29/08
Eli
Lilly asks FDA to add pain indication to label of depression drug
Cymbalta
Yahoo/AP
5/29/08
Biotech’s
Biggest Weekend
CNBC
5/29/08
Amgen
Investors Waiting for More Results on D-mab
SeekingAlpha
5/29/08
Can
Takeda (or Roche, or Merck, or...) Afford to Ignore RNAi?
SeekingAlpha
5/29/08
Pharmaceutical
Facts Investors Should Know
SeekingAlpha
5/29/08
Wyeth
vaccine candidate gets special FDA designation, allowing for faster
review
Yahoo/AP
5/29/08
Pfizer
Counterattacks on Smoking-Cessation Drug Chantix
WSJ
Online 5/29/08
Texas
appeals court reverses $26 million verdict against Merck in first
Vioxx case
Yahoo/AP
5/29/08
Bristol-Myers
Squibb to acquire Kosan Biosciences
Marketwatch
5/29/08
Ligand:
A Blood Bath
Forbes
5/29/08
Merck/Schering Cholesterol Drug Prescriptions Down 11% In April
CNN
Money 5/29/08
Genentech's
Avastin Sales Rose in April, Analyst Says
Bloomberg
5/29/08
Antisoma
receives USD 25 million milestone payment from Novartis
Trading
Markets, CA 5/29/08
Valuing
Pharma Like Metal Benders
Forbes
5/29/08
Eisai Sells 120 Billion Yen Bonds to Fund Takeover
Bloomberg
5/29/08
Sciele
hypertension franchise banks on new version
Guardian,
UK 5/29/08
Alexion
rated 'Buy' as analyst says Soliris revenue could surpass $1 billion
per year
Yahoo/AP
5/29/08
US
FDA proposes new pregnancy labels for medicines
Stockhouse
5/29/08
FDA
accepts Watson's NDA for bladder drug
Pharmaceutical
Business Review 5/29/08
|
|
GSK
dealt twin blow by brokers
FT.com
5/28/08
Amgen Drug Improves Bone Density in Study
TheStreet.com
5/28/08
Imclone's
Trading Signals Failure to Beat Avastin
Bloomberg
5/28/08
Trade
idea for Glaxo (GSK) downgrade
Blogging
Stocks 5/28/08
FDA
official sees some delays over safety
Reuters
5/28/08
New
And Improved Drugs? No Thanks, Pharma Cos Are Being Told
CNN
Money 5/28/08
Sector
Wrap: Cancer Drug developers
Forbes
5/28/08
AstraZeneca sues to block generic
The
News Journal, DE 5/28/08
Everyone
Wants A Piece Of Alnylam
Forbes
5/28/08
Generics Catching Up with Big Pharma
Zacks.com
5/28/08
Immunogen
and Seattle Genetics: Verging on an Inflection Point
SeekingAlpha
5/28/08
Livin'
la VIVUS Loca
Motley
Fool 5/28/08
What's Next For Chantix?
InjuryBoard
5/28/08
Study
shows benefit of statins before heart surgery
Reuters
5/28/08
Lehman
upgrades Amylin, saying Icahn involvement will get investors'
attention
Yahoo/AP
5/28/08
Australian
Federal Court Upholds Pfizer's Basic Lipitor Patent - quick facts
RTT
News 5/28/08
Favrille Ends Trials With Nothing Left
Forbes
5/28/08
PDL for Sale, Cheap!
Motley
Fool 5/28/08
Express Scripts Averts Suit
WSJ
Online 5/28/08
Dr.
Reddy's CFO Says 2009 Profit Growth to Be ``Substantial''
Bloomberg
5/28/08
Another
potential $1B deal for RNAi drug technology
Hemscott,
UK 5/28/08
New
Eloxatin(R) (oxaliplatin injection) Prescribing Information in
the U.S. Includes Six-Year Overall Survival Data
PR
Newswire 5/28/08
Santaris
Says Human Test of Liver Drug Is First of Its Kind
Bloomberg
5/28/08
WuXi PharmaTech reaffirms 2008 revenue outlook of $280 million
to $300 million
Yahoo/AP
5/28/08
|
|
Novartis
Looks For Magic Pill
Forbes
5/27/08
Opening View: GlaxoSmithKline and Novartis AG in the Pharmaceutical
Spotlight
Schaeffers
Research 5/27/08
ASCO:
Whose Presentations Look the Most Promising?
Seeking
Alpha 5/27/08
Merck:
Study shows odanacatib Reduced Markers of Bone Turnover in Women
with Breast Cancer and Bone Metastases - quick facts
RTT
News 5/27/08
10 Biotechs in Stem Cells that Could Profit Under the Democrats
Seeking
Alpha 5/27/08
Antipsychotics
given for dementia pose risks-study
Reuters
5/27/08
Takeda's
Diabetes Drug Shows Promise, Analysts Say
Bloomberg
5/27/08
Bristol-Myers
pulls European application for DuoCover
Marketwatch
5/27/08
Biotech stocks mostly rise with the broader market following housing
report
Yahoo/AP
5/27/08
King
Pharmaceuticals Files Citizen Petition Relating to New Altace
Patent
Seeking
Alpha 5/27/08
Drug stocks mixed; Favrille tanks on drug study
Marketwatch
5/27/08
Sanofi:
Node-Negative Early Stage Breast Cancer Patients Benefit from
Taxotere(R)-Based Chemotherapy
Yahoo
5/27/08
Roche Experimental Diabetes Drug Seems Safe, Effective
Easy
Bourse, France 5/27/08
Morgan
Stanley cuts GlaxoSmithKline to underweight
Marketwatch
5/27/08
Alnylam
Pharma, Japan's Takeda sign $1B RNAi deal
Forbes
5/27/08
Elan may spin off contract manufacturing arm
InPharmaTechnologist
5/27/08
More
Than 700 Biotechnology Industry Leaders Attend CED’s Biotech
2008
Carolina
Newswire 5/27/08
|
|
Novartis
MS Drug, Rival to Bayer's, Wins EU Approval
Bloomberg
5/26/08
Following
the China Biopharma Beat
SeekingAlpha
5/26/08
Memorial
Weekend Pharma Financing
SeekingAlpha
5/26/08
ImClone
Investors Prepare to FLEX
TheStreet.com
5/26/08
Review
suggests asthma drugs safe, effective in COPD
Reuters
5/26/08
Acne
drug linked to depression
Reuters
5/26/08
For
Brain Cancer Drugs, a Glimmer of Progress
Red
Orbit 5/26/08
BioPhausia
Rises Most in 5 Months on AstraZeneca Deal
Bloomberg
5/26/08
FDA's
footdragging hurts Canada's biotech firms
Yahoo/Reuters
5/26/08
Betting on Biotech
Profits elusive, but firms still lure investors
The
Reporter, CA 5/26/08
Chantix
Side-Effects May Halt Rare Pfizer Success Story
Seeking
Alpha 5/25/08
Icahn
Boosts Stake in Amylin to 6.5%, Seeks Additional Talks
Seeking
Alpha 5/25/08
Drug
stocks slide, Alkermes falls on downgrade
MarketWatch
5/25/08
Wyeth Drags Through Drug Approval Process
Forbes
5/25/08
Progenics'
Mixed Trial Data
Motley
Fool 5/25/08
GTx
shares fall on prostate cancer drug trial
Yahoo/AP
5/25/08
Osiris Therapeutics: Bone Regeneration = Big Bucks
Seking
Alpha 5/25/08
Bioheart,
Inc. Reports Receipt of Notification from NASDAQ Regarding Non-Compliance
with Continued Listing Requirements
Yahoo
5/25/08
Sunesis
Pharmaceuticals starts another test of cancer drug
Bizjournals
5/25/08
MedImmune
settles lawsuit with rival
Bizjournals
5/25/08
Lipid
Sciences Receives Marketplace Rule 4310(c)(3) Notice From NASDAQ
Yahoo
5/25/08
FDA
still awaiting OK to open China offices
PhillyBurbs,
PA 5/25/08
|
|
Current
Yields Makes Bristol Myers Squibb a Buy
Seeking
Alpha 5/22/08
Regeneron
Can't Fast-track Ovarian Cancer Drug
Forbes
5/22/08
FAA Bans Pilot Use of Pfizer's Chantix
The
Street 5/22/08
Myriad
licenses Alzheimer's drug to Lundbeck
Reuters
5/22/08
Landmark
ATHENA Study Findings With Multaq®(dronedarone) Show 24% Reduction
in Cardiovascular Hospitalisation or Death in Patients With Atrial
Fibrillation
PR
NewsWire 5/22/08
Teva
generic for Eli Lilly premenstrual drug OK'd
BizJournals
5/22/08
Hapoalim
cuts Teva
Globes,
Israel 5/22/08
The
big pharmaceutical companies are on the prowl
Money
Central 5/22/08
Smaller
biotechs shine while big names disappoint
Boston
Globe, MA 5/22/08
Genomics
Is Transforming The Pharmaceutical Industry
EarthTimes
5/22/08
Lotus
Pharmaceuticals, Inc. Announces First Quarter 2008 Results
CNN
Money 5/22/08
Top
PROs have spoken out about the need for the pharmaceutical industry
to urgently improve its reputation
PR
Week 5/22/08
Wyeth
and Progenics Announce Preliminary Clinical Trial Results for
RELISTOR Oral and Intravenous Formulations
Yahoo
5/22/08
Adolor
And GlaxoSmithKline Announce FDA Approval Of Entereg(R) (alvimopan)
For The Management Of Postoperative Ileus (POI)
Medical
News Today 5/22/08
Plexxikon
Announces Preclinical Data Demonstrating Dramatic Improvement
in Key Symptoms of Polycystic Kidney Disease
Street
Insider 5/22/08
Jennerex
Publishes Promising Results From Cancer Clinical Trial Of JX-594
In Lancet Oncology
Medical
News Today 5/22/08
NeoPharm
Announces Execution of a Letter of Intent with SIRO ClinPharm
for a planned Confirmatory Phase III Trial for Cintredekin Besudotox
(IL13-PE38QQR)
Yahoo
5/22/08
Sunesis
Pharmaceuticals Initiates Phase 2 Clinical Trial Of Voreloxin
(SNS-595) In Acute Myeloid Leukemia
Medical
News Today 5/22/08
ARIAD
Initiates Phase 1 Clinical Trial of its Investigational Oral Multi-Targeted
Kinase Inhibitor, AP24534, in Patients with Hematological Cancers
Yahoo 5/22/08
Watson
Announces Positive Data For Its New Investigational Products For
Benign Prostatic Hyperplasia And Overactive Bladder
Medical
News Today 5/22/08
Abbott
Presents Long-Term Data From Extension Study Showing Adult Crohn's
Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission
Medical
News Today 5/22/08
The
FDA's Cancer Chief Speaks Out
Business
Week 5/22/08
|
|
Once
Bitten, Merck Halts Cholesterol Drug Study
WSJ
Online 5/21/08
Merck
settles complaints over Vioxx ads
The
Day, CT 5/21/08
Just
What the Doctor Ordered for Big Pharma
Yahoo/Portfolio.com
5/21/08
Wyeth Files Suit Against Sandoz Over Generic
WSJ
Online 5/21/08
Big
Pharma biotech deals worth $27B in'07
Newark
Star Ledger, NJ 5/21/08
Daiichi
Sankyo to Buy U3 Pharma for $235 Million To Gain Two Cancer Drugs
Bloomberg
5/21/08
Glaxo
says Advair sales to top 4 bln pounds in 2008
Reuters
5/21/08
Amgen
Prevents Biotechs from
Reaching Profitability
Seeking
Alpha 5/21/08
Biotechnology
stocks open lower even as broader markets mixed ahead of oil inventory
report
Yahoo/AP
5/21/08
Adolor
Soars After U.S. Approves Entereg for Constipation
Bloomberg
5/21/08
Sanofi-Aventis, Regeneron ovarian cancer drug misses goal in mid-stage
trial
Yahoo/AP
5/21/08
Enzon Shareholder Demands Possible Sale of Commercial Operations
Be Explored
Seeking
Alpha 5/21/08
Study
Analyzed SYMBICORT(R) in Children with Persistent Asthma
Yahoo
5/21/08
Schering-Plough To Initiate Phase III Studies With HCV Protease
Inhibitor Boceprevir in Previously Untreated Hepatitis C Patients
and Those Who Failed Prior Treatment
Yahoo
5/21/08
Congressmen ask pharma heads to change DTC guidelines
PharmaTimes
5/21/08
Avant, Pfizer brain cancer vaccine licensing deal clears Federal
Trade Commission
Yahoo/AP
5/21/08
Teva
Announces Approval of Generic Sarafem(R) Pulvules(R)
Yahoo
5/21/08
Cell Genesys Reports Encouraging Interim Data From Phase 1 Clinical
Trial of CG0070 in Recurrent Bladder Cancer
Yahoo
5/21/08
Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin
(SNS-595) in Acute Myeloid Leukemia
Yahoo
5/21/08
Basilea
Shares Rise Most in 3 Weeks on Ceftobiprole Study
Bloomberg
5/21/08
|
|
AstraZeneca
Gains as New Court Hearing Lifts Seroquel Cloud
Bloomberg
5/20/08
Amgen
Bone Drug Beats Fosamax in Trial
WSJ
Online 5/20/08
Why
Selling Drugs is Like Selling Ketchup
WSJ
Online 5/20/08
Can
cancer drugs help pharma sales?
Blogging
Stocks 5/20/08
Amgen
Keeps Biotechs From Reaching Industry Milestone
CNBC
5/20/08
Are
Hopes Getting Too High for Genentech?
Schaeffers
Research 5/20/08
CEO Gambles on a Novartis Makeover
WSJ
Online 5/20/08
Cramer:
How An Obama Win Would Impact Healthcare Stocks
SeekingAlpha
5/20/08
Doctors
moving to limit gifts from drug firms
Baltimore
Sun, MD 5/20/08
Profits
Elusive, But Biotech Still Lures Investors
CNN
Money 5/20/08
New
Pfizer Data In Lung Cancer, Ewing's Sarcoma, Prostate Cancer And
Other Difficult-to-Treat Tumor Types To Be Presented At ASCO
Medical
News Today 5/20/08
Lilly
steps up in support of troops
Indianapolis
Star, IN 5/20/08
What
Will Icahn Do With Amylin?
Motley
Fool 5/20/08
Potential
for Huge Profits Awaits Big Pharma Companies
Indianapolis
Star, IN 5/20/08
Are
Impotence Drugs Good for Your Heart?
CNBC
5/20/08
Bayer
and Onyx's Nexavar improves overall survival in liver cancer study
Pharmaceutical
Business Review 5/20/08
New analysis boosts drug's prostate cancer value
Reuters,
UK 5/20/08
Dr.
Reddy's Profit Declines on Lower U.S. Sales
Bloomberg
5/20/08
Antisoma
boosts late-stage pipeline with Xanthus purchase
PharmaTimes,
UK 5/20/08
Positive
Clinical Data with Santarus’ ZEGERID Capsules in Controlling
24-Hour Gastric Acidity
Businesswire
5/20/08
Eisai
says Rufinamide results positive in Lennox-Gastaut Syndrome tests
Interactive
Investor 5/20/08
BioSeek to Collaborate With Merck Serono to Assess Potential Drug
Candidates
Businesswire
5/20/08
|
|
A
Contrarian Look at Pfizer
SeekingAlpha
5/19/08
Pfizer
And Amgen Trade "Political" Places
CNBC
5/19/08
FDA
stresses birth defect risks with Roche drug
Yahoo/AP
5/19/08
Glaxo gets approval for bird flu vaccine
Yahoo/AP
5/19/08
The Vytorin saga: should Schering Plough's chief give back his
bonus?
Newark
Star Ledger, NJ 5/19/08
Novartis reports progress with a cancer treatment
Marketwatch
5/19/08
Glaxo's new chief Witty faces tough job
Reuters,
UK 5/19/08
Biotechnology
stocks waver with broader market ahead of economic report
Yahoo/AP
5/19/08
Drug
stocks mixed; Novartis climbs on cancer drug study
Marketwatch
5/19/08
FDA
agrees to study Botox rival
Guardian,
UK 5/19/08
Study
Suggests that Adding Singulair to Advair Offers no Additional
Improvement in Overall Asthma Control
Yahoo
5/19/08
Biogen
reiterates long-term financial forecast
Marketwatch
5/19/08
Schering-Plough
Extends Antibody Alliance with MorphoSys
PharmaLive
5/19/08
Pfizer
closes plant earmarked for Exubera
InPharmaTechnologist
5/19/08
Alimta
data boosts survival prospects of lung cancer patients
PharmaTimes,
UK 5/19/08
Pharmasset chooses lead hepatitis C drug candidate
Yahoo/AP
5/19/08
InterMune drug gets fast-track status
bizjournals.com
5/19/08
Zentiva
1Q Net Profit CZK469.7 Million, Beating Expectations
Easy
Bourse, France 5/19/08
|
|
Pfizer's
Chantix and Celebrex: An Anti-Smoking Double Play
Seeking
Alpha 5/18/08
Sinovac’s
Q1 Doubles Year-Earlier Results
Seeking
Alpha 5/18/08
Fledglings
targeted by Big Pharma
Sunday
Herald, UK 5/18/08
Patients
With Asthma and Seasonal Allergies Respond Better to Advair(R)
for Their Asthma Than Singulair(TM)
Yahoo
5/18/08
Court
paves way for Teva's generic Lovenox
Globes,
Israel 5/18/08
Company
developing nasal gel MRSA drug
Reuters
5/18/08
Genentech,
Celgene Seen As Winners In ASCO Data Deluge
CNN
Money 5/17/08
Investors
Aplenty For Pharmacopeia
Forbes
5/17/08
Genentech Advances Avastin Trial in Colon Cancer Patients
International
Business Times 5/17/08
Schering-Plough
CEO says rebuilding plan on track
Yahoo/AP
5/17/08
Pharmasset shares up; analysts upbeat on hepatitis candidate
Forbes
5/17/08
Drug stocks dip, but AstraZeneca gains on Iressa
Market
Watch 5/17/08
Eli
Lilly's Alimta Shows Promise in Cancer Study
The
Street 5/17/08
MS
Drug Partnership Raises New Hopes In A Tough Market
Yahoo/Inverstor's
Business Daily 5/17/08
Array
BioPharma and AstraZeneca Announce New Phase 2 Development Plans
for the Investigational Anti-Cancer Drug AZD6244 (ARRY-886)
Red
Orbit, TX 5/17/08
FDA
stresses birth defect risks with Roche drug
Yahoo/AP
5/17/08
Catalyst loss grows in Q1
MIlwaukee
Business Journal, WI 5/17/08
Biovail
Subsidiary Reaches Settlement with United States Department of
Justice
Ad-Hoc-News,
Germany 5/17/08
Salix
Pharmaceuticals Receives Approvable Letter from FDA for Balsalazide
Tablet
Genetic
Engineering News 5/17/08
Antisoma
buys Xanthus for $52M
Fierce
Biotech 5/17/08
KV
Pharmaceutical Wins Approval for Generic Anti-Hypertension Drug
Red
Orbit, TX 5/17/08
Alliance
Pharma says re-evaluating Isprelor development; Phase III inadequate
Hemscott,
UK 5/17/08
Accentia
Biopharmaceutical loss widens
Bizjournals
5/17/08
Inspire
paid $1.25M for achieving milestone
San Anotnio Business Journal, TX 5/17/08
Paladin
Labs Inc.: Plan B Emergency Contraceptive Now Over the Counter
in Canada
Pharma
Live 5/17/08
Biophage
Pharma announces sale of Immunotox Labs Division to Validapro
BioSciences Inc
Fox
Business 5/17/08
Oragenics,
Inc. (ONI BioPharma Inc.) Receives Notification Letter From American
Stock Exchange
CNN
Money 5/17/08
RxElite,
Inc. Delays First Quarter 2008 Earnings Filing
CNN
Money 5/17/08
Immunosyn
Corporation Files 10-Q
Yahoo
5/17/08
New
Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib)
for Injection Based Therapies in Patients With Newly Diagnosed
Multiple Myeloma
PR
NewsWire 5/17/08
Memory
Pharmaceuticals Highlights Progress with Key Programs at its R&D
Day
CNN
Money 5/17/08
Significant
Anti-Tumor Activity Of NKTR-102 In Patients With Refractory Solid
Tumors; Interim Data Published In ASCO 2008 Proceedings
Medical
News Today 5/17/08
Novel
enzyme inhibitor paves way for new cancer drug
Cancer
Focus 5/17/08
Another
push to limit generics (in Florida)
Sarasota Herald-Tribune, FL 5/17/08
Nonprofits
Become Funding Source for Smaller Biotechs
Bioworld
5/17/08
|
|
Celebrex
Shows Benefit In First-of-its-kind Lung Cancer Chemoprevention
Trial
Science
Daily 5/16/08
Sanofi shares gain on hopes for heart drug sales
Forbes/Reuters
5/16/08
Rumor Mill: Pfizer Buying MediGene?
SeekingAlpha
5/16/08
Oncology Conference Countdown: What Will Pharma and Biotech Companies
Report?
SeekingAlpha
5/16/08
Imclone's Gene Test Battle
Forbes
5/16/08
Cancer
Study Bonanza Reveals Likely Winners
WSJ
Online 5/16/08
Strength
and Innovation of Novartis Oncology Products and Pipeline With
Potential to Improve Patient Treatment Demonstrated By More Than
170 Abstracts at ASCO Annual Meeting
RedOrbit
5/16/08
AstraZeneca:
new Seroquel label cannot prevent the inevitable
Pharmaceutical
Business Review 5/16/08
Inspire
Pharmacueticals gets $1.5 million milestone payment from Japanese
partner
Yahoo/AP
5/16/08
Genentech's
Avastin Passes Key Safety Test
TheStreet.com
5/16/08
Genentech:
Phase III Avastin colon cancer trial done by 2009
Marketwatch
5/16/08
Herceptin enhances Tykerb for breast cancer -study
Reuters,
UK 5/16/08
Amgen's
Denosumab Cuts Fractures in Cancer Patients
Bloomberg
5/16/08
Why
is Wall Street Ignoring ImmunoGen?
SeekingAlpha
5/16/08
Buy
Novo Nordisk (NOVOB:xcse) on more efficient dosing pen
FXStreet.com
5/16/08
Array
and AstraZeneca announce Phase II cancer trial plans
Pharmaceutical
Business Review 5/16/08
Dynavax
shares plummet on allergy drug failure
Yahoo/AP
5/16/08
Why I'm Cutting WuXi PharmaTech
SeekingAlpha
5/16/08
3SBio’s
Q1: Revenues Rise, Net Income Lags
SeekingAlpha
5/16/08
Pharmacopeia's
First-in-Class Investigational Therapy PS433540 Achieves Statistically
Significant Reductions in Blood Pressure in Hypertensive Patients
PharmaLive
5/16/08
|
|
Court
Overturns Merck Vioxx Verdict
TheStreet.com
5/15/08
Can
Cancer Cure Pfizer?
Forbes
5/15/08
Options Update: Bears Flock to Schering-Plough After a Positive
Analyst Comment
Schaeffers
Research 5/15/08
Teaching
Old Drugs New Tricks
Motley
Fool 5/15/08
Merck
and Ranbaxy: Burning Questions
Star
Ledger, NJ 5/15/08
Sanofi:
U.S. court affirms Lovenox patent not enforceable
Marketwatch
5/15/08
Migraine
Medicines May Cause Potentially Deadly Brain Syndrome
Bloomberg
5/15/08
Sales
of cancer drugs may soar
News&Observer,
NC 5/15/08
Drug
Spending Moves Up for Diabetes, Down for Cholesterol
WSJ
Online 5/15/08
Bayer
pulls Trasylol supplies after study
National
Post, Canada 5/15/08
Three
Game-Changers For Big Pharma
Seeking
Alpha 5/15/08
Pfizer
names head of oncology business unit
Yahoo/AP
5/15/08
Generic Drug Prices for Elderly Fell 10% Last Year, AARP Says
Bloomberg
5/15/08
Simcere Granted SFDA Approval for Generic Antibiotic
Seeking
Alpha 5/15/08
IMS
Sees Strong Cancer Drug Sales Growth, But Moderating
CNN
Money 5/15/08
Abraxis BioScience swings to a 1st-quarter profit on sales of
breast cancer drug Abraxane
Yahoo/AP
5/15/08
Pipeline a Bit Early on Alexza
Yahoo/Zacks.com
5/15/08
J&J Stent Ad Under Fire in Medical Journal
CNBC
5/15/08
A.P. Pharma's Q1 loss widens on R&D costs
bizjournals.com
5/15/08
Genelabs
Q1 loss more than doubles
bizjournals.com
5/15/08
FDA
puts Geron spinal cordinjury drug on hold
Yahoo/AP
5/15/08
Novavax
Completes Enrollment in Phase I/IIa Pandemic Influenza Vaccine
Clinical Trial
Yahoo
5/15/08
|
|
Novartis
stars among European cancer drug hopes
Reuters
5/14/08
New
Use Pops Up For Viagara
Forbes
5/14/08
Sanofi, Bristol's Plavix Failed to Strengthen Dialysis Veins
Bloomberg
5/14/08
Glaxo
says cervical cancer vaccine works for longer
Reuters
5/14/08
Lilly
Backs Grassley Bill
Forbes
5/14/08
AstraZeneca's
Seroquel gets FDA approval
Boston
Globe, MA 5/14/08
Most
Americans on meds now: study
Chicago
Sun Times, IL 5/14/08
MediGene
Rises on Market Speculation Pfizer May Bid
Bloomberg
5/14/08
Drug
sales slip among big changes
Star
Ledger, NJ 5/14/08
Palatin
layoffs continue
Star
Ledger, NJ 5/14/08
Merck
Signs $100M Development Deal with Ranbaxy
Pharma
Exec 5/14/08
Ahead
of the Bell: Drug and device lawsuits
Hemscott,
UK 5/14/08
Schering-Plough
leads drug stocks higher
Marketwatch
5/14/08
Genoptix:
Little-Known Biotech with Strong Focus and Growth
SeekingAlpha
5/14/08
In
a Phase II Study, Novartis Meningitis B Vaccine Has Potential
to Produce a Protective Immune Response in Infants, the Age Group
Most at Risk
Trading
Markets 5/14/08
Mylan begins selling generics of GlaxoSmithKline antidepressant
Paxil
Yahoo/AP
5/14/08
New
Data Shows 45 Percent of Patients with Stage 1 Hypertension Reached
Normotension with BENICAR(R) and BENICAR HCT(R)
Street
Insider 5/14/08
BSX Meets With Much Approval, Biogen and Icahn Set the (Showdown)
Date, Fate’s Fate Revealed, Win Free Stuff, & More Life
Sciences News
Xconomy
5/14/08
Novartis
says tests show blood pressure drug Exforge efficient in sub-group
Hemscott,
UK 5/14/08
FDA
calls Novartis promotional magnet 'misleading'
CNN
Money 5/14/08
Daiichi
Sankyo profits will be hurt by prasugrel launch costs
PharmaTimes,
UK 5/14/08
NicOx
reports first quarter 2008 financial results
PharmaLive
5/14/08
Mylan
shares slide after dimmer outlook
Trading
Markets 5/14/08
Amarin privately placing up to $60 mln in ADRs
Hemscott,
UK 5/14/08
|
|
Another
Breach of Employee Data at Pfizer
WSJ
Online 5/13/08
AstraZeneca's
Toprol Raises Risk of Death, Study Says
Bloomberg
5/13/08
Drug
sales representatives may face new competition in hospital halls
and doctor offices — from the federal government
Wilkes-Barre
Times Leader, PA 5/13/08
GSK's
Tykerb up against Herceptin in early breast cancer study
PharmaTimes,
UK 5/13/08
Biotech:
crunch time for UK biotech
Telegraph,
UK 5/13/08
Schering-Plough
May Settle for Less on Clotting Partnership
WSJ
Online 5/13/08
ImClone Falls After Analyst Says Sell, Citing Data
Bloomberg
5/13/08
ImClone
'Eager' for Erbitux Data Release
TheStreet.com
5/13/08
Daiichi
Sankyo forecasts surprise sharp profit fall
Forbes
5/13/08
FDA approves Novo Nordisk's clot therapy
Pharmaceutical
Business Review 5/13/08
Analyst
Upbeat on Allergan, Alcon, Cautious on Advanced Medical
Orange
County Business Journal, CA 5/13/08
Merging Mylan Meanders Through 2008
Motley
Fool 5/13/08
Myriad
Options on Alzheimers Disease
Seeking
Alpha 5/13/08
Generic
Plavix opens door for API manufacturers
InPharma
Technologist 5/13/08
NicOx
Announces Initiation of First Phase 1 Study of Investigational
Nitric Oxide-Donating Agent in Hypertensive Patients by Merck
& Co., Inc.
Genetic
Engineering News 5/13/08
Six Significant Gene Therapy Stocks
SeekingAlpha
5/13/08
Novacea
slashing work force in wake of failed drug
CNBC
5/13/08
Chinese
drugs seen driving down generic prices
Reuters
5/13/08
Viagra
may help heart in muscular dystrophy: study
Reuters
5/13/08
Eli
Lilly to help train doctors on drug-resistant TB
Reuters
5/13/08
Barr
Pharmaceuticals Get FDA Approval For Generic Contraceptive Amid
Patent Dispute
Trading
Markets, CA 5/13/08
Beta
blockers before surgery raise risks: Study
Toronto
Star, Canada 5/13/08
Valeant
Announces Successful Completion of Retigabine Phase III Epilepsy
Program Validating Novel Mechanism of Action
Trading
Markets, CA 5/13/08
|
|
Barr
Announces Approval of Generic Yasmin(R)
Fox
5/11/08
Hi-Tech
Pharmacal Launches Authorized Generic of Warner Chilcott's Dovonex(R)
Scalp Solution
Fox
5/11/08
Sanofi/Bristol-Myers
Battle For Patent
Forbes
5/10/08
Takeda's Results Cause Hypertension
Forbes
5/10/08
Santarus Weighted to One Product
Trading
Markets 5/10/08
Mylan
shares slide after dimmer outlook
Pittsburgh
Post Gazette, PA 5/10/08
Bristol-Myers
Squibb, Otsuka Get FDA Approval for Expanded Use of Abilify
NJBIZ,
NJ 5/10/08
Par
Pharma 1Q earnings fall, but shares rise on adj. profit
Yahoo/AP 5/10/08
EUSA
Pharma Completes Acquisition Of Cytogen Corporation
CNW
Telbec 5/10/08
Health
Winners & Losers: Alnylam
The
Street 5/10/08
PDL
BioPharma shares hit 5-year low on wider 1Q loss
Yahoo/AP
5/10/08
Keryx
Biopharmaceuticals, Inc. Announces First Quarter 2008 Financial
Results
Sun
Herald 5/10/08
Bionovo
Reports First Quarter 2008 Financial Results
News
Blaze 5/10/08
Alnylam
shares soar on narrower 1Q loss, surge in revenue
Boston
Globe 5/10/08
Genaera
Corporation Announces First Quarter Financial Results
MSN
Money 5/10/08
Vivus
reports $7.1 million loss in first quarter
Conde
Nast Porfolio 5/10/08
BioSante
Pharmaceuticals Reports First Quarter 2008 Financial Results
Ad-Hoc-News 5/10/08
LifeCycle
Pharma's dyslipidemia drug found effective in Phase II study
Pharmaceutical
Business Review 5/10/08
EpiCept
Announces Receipt of Nasdaq Determination
Centre
Daily Times, PA 5/10/08
Semi-Annual
Changes to the NASDAQ Biotechnology Index
Exchange
News Direct, UK 5/10/08
Report:
FDA warns on Heparin
MSN
Money 5/10/08
|
|
|
